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Proteases play an intricate role in the numerous functions of a living organism. 
Proteases are responsible for the cleavage of proteins into smaller fragments by 
catalysing the hydrolysis of peptide bonds. The class of cysteine proteases have a 
cysteine thiol group in their active site have been found in lower and higher 
organisms. They have been investigated as promising drug targets for various 
diseases due to their fundamental functions in catabolism and protein processing. 
The thermal stability of a protease is a key characteristic feature that is largely 
dependent on its amino acid sequence and composition and quantified through the 
determination of its melting temperature (TM). Papain is the most well 
characterised cysteine protease and is commonly used as a model for other 
cysteine proteases. Congopain is the major cysteine protease of Trypanosoma 
congolense which has been identified as the main causative agent of 
trypanosomiasis in livestock. The thermal stability for papain and congopain were 
investigated in this study via the thermal shift assay. Papain was purchased and 
the catalytic domain of congopain was expressed using the Pichia pastoris yeast 
expression system. The thermal stability of the proteases were determined under 
neutral pH conditions and the effect of pH and ligand binding were evaluated to 
determine if the proteases could be further stabilised. The most stable forms of 
papain and the catalytic domain of congopain in its monomeric form was observed 
at pH 5.0 with 50 µM chymostatin. The thermal stability of both cysteine proteases 
was successfully evaluated via the thermal shift assay and conditions to further 
stabilise papain and the catalytic domain of congopain were determined. The 
thermal shift assay has been proven to be a reliable technique in identifying factors 
which increase the stability of a protein. More specifically, the technique serves as 
a simple and primary diagnostic tool to screen potential inhibitors of a protein and 
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1. LITERATURE REVIEW 
1.1. Function, classification and nomenclature of proteases  
Proteases (also known as proteinases, proteolytic enzymes or peptidases) are 
responsible for the cleavage of proteins into peptides and amino acids as they catalyse 
the hydrolysis of peptide bonds. Numerous biological processes, in organisms ranging 
from bacteria and parasites to higher organisms such as mammals, are fundamentally 
dependent on this catalytic action (Otto and Schirmeister, 1997; Grzonka et al, 2001). 
Proteases are classified as either endoproteases or exoproteases – dependent on the site 
of hydrolysis in the peptide chain. Endoproteases catalyse the cleavage of peptide bonds 
within the polypeptide chain while exoproteases catalyse the cleavage of peptide bonds 
at the N-terminal or C-terminal ends (Otto and Schirmeister, 1997; Mótyán et al, 2013). 
Proteases are further classified - according to the reactive groups at the active site of 
the enzyme - as aspartic, glutamic, metallo, serine, threonine and cysteine proteases 
(CPs) or asparagine peptide lyase.  
 
For catalysis, the aspartic, glutamic and metallo proteases activate a water molecule 
which then undergoes a nucleophilic attack on a peptide bond. Serine, threonine and 
cysteine proteases employ a two-step hydrolysis mechanism whereby a residue within 
the enzyme active site is first activated to act as a nucleophile to attack the substrate 
peptide bond. The nucleophilic attack results in the formation of an intermediate 
comprising of the enzyme covalently linked to the N-terminal half of the substrate. 
Hydrolysis is completed via the activation of water to hydrolyse the intermediate.  
These classes of proteases can then be classified into different families based on their 
sequence similarities and within each family they can be categorised into different clans 
based on structure-based classification (Rawlings and Barrett, 1993; Rawlings et al, 
2009; Rawlings et al, 2018).  
 
The cleavage site specificity of proteases is described using nomenclature proposed by 
Schechter and Berger (1967). As illustrated in Figure 1.1, the subsites on the protease 
that interact with the substrate amino acid residues are labelled S and the substrate 
amino acid residues are labelled P (Schechter and Berger, 1967; Hooper, 2002). The 
subsites are numbered outward in both directions from the catalytic site where S1, S2, 
S3, etc are numbered towards the N-terminal and S1', S2', S3', etc are numbered towards 
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the C-terminal. The substrate amino acid residues are numbered from the scissile bond 
outward to match the subsites of the protease (Schechter and Berger, 1967; Hooper, 









Figure 1.1: Nomenclature of the substrate specificity of a protease. The cleavage site and 
the location of the substrate scissile bond are between P1 and P1'. The protease active site shows 
the specific subsites numbered to correspond with the substrate amino acid residue in the 
substrate sequence. Taken from Song et al., 2011. 
 
1.2. Cysteine Proteases  
Cysteine proteases, initially termed thiol proteases, are characterised by the presence of 
an active site cysteine thiol group (Otto and Schirmeister, 1997; Grzonka et al, 2001) 
and have been found in plants, mammals, viruses, bacteria, protozoa and most recently 
in fungi (Otto and Schirmeister, 1997; Mótyán et al, 2013). Cysteine proteases vary 
greatly in molecular weight with papain, congopain and cathepsin K possessing 
molecular weights between 20 - 33 kDa while the molecular weight of calpains can 
exceed 80 kDa. Cysteine proteases yield maximum hydrolytic activity at a pH range 
between 4 and 6.5 (Otto and Schirmeister, 1997). 
During the hydrolysis of a peptide (Figure 1.2), the sulfhydryl of the active site cysteine 
(Cys-25 in Figure 1.2) initiates a nucleophilic attack on the carbonyl carbon of the 
scissile bond of the bound substrate and forms a tetrahedral intermediate that is 
stabilised by the oxyanion hole (Lecaille et al, 2002). The stabilised tetrahedral 
intermediate is then transformed into an enzyme-substrate thiol ester while releasing 
the C-terminal segment of the substrate. The enzyme-substrate thiol ester is hydrolysed, 
resulting in the formation of a second tetrahedral intermediate that undergoes 
deacylation which separates the free enzyme and the N- terminal segment of the 




Figure 1.2: The mechanism of peptide hydrolysis by cysteine proteases. The cysteine of the 
catalytic triad initiates a nucleophilic attack on the bound substrate resulting in a tetrahedral 
intermediate which undergoes acylation to form a thioester that is hydrolysed to form the 
second tetrahedral intermediate which undergoes deacylation. Taken from Lecaille et al, 2002. 
 
1.3. Papain 
The papain-like cysteine protease family is the best characterised of the cysteine 
proteases and has been duly classified as the C1 family. The C1 family contains 
proteases with a wide range of activities (including those that have no catalytic activity) 
(Balls and Lineweaver, 1939; Patel et al, 2012; Liu et al, 2018). Of these, papain was 
first isolated and purified in its native crystalline state in 1937 from the latex of the 
green fruit of Carica papaya (Balls et al, 1937; Monti et al; 2000). The method was 
later modified (Kimmel and Smith, 1954), which then became the standard for the 
purification of papain from papaya latex. This method involved the extraction of the 
latex from the papaya, removal of insoluble material in the extract at pH 9.0, followed 
by ammonium sulfate precipitation and three recrystallisation steps (Monti et al, 2000; 
Malek et al, 2016). The method yielded three forms of papain - active papain, 
activatable papain and non-activatable papain. In the active papain the thiol group is 
fully reduced whereas the activatable papain is inactive but can be converted to active 
papain via reaction with thiols. The non-activatable papain form, however, cannot be 
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converted to active papain by thiol reactions (Monti et al, 2000; Malek et al, 2016). 
This method has been modified over time to increase the quality and the yield of active 
papain (Monti et al, 2000; Malek et al, 2016). The final purified papain product sought 
is white in colour and is completely soluble in water and glycerol. The final quality of 
the purified papain for industrial use is determined by colour, moisture content, total 
ash content, the absence of contaminants and proteolytic activity (Monti et al, 2000; 
Malek et al, 2016). 
 
Papain has a molecular weight of 23.41 kDa and is comprised of 345 amino acid 
residues with three disulfide bridges and an active site sulfhydryl group (Amri and 
Mamboya, 2012). The 345 amino acid residues constitute a signal sequence (18 amino 
acids), a propeptide region (115 amino acids) and the mature peptide (212 amino acids) 
(Amri and Mamboya, 2012). The three dimensional structure of papain consists of two 
distinct structural domains (Figure 1.3). The two domains are defined as the L-domain, 
which is characterised mainly by the presence of α helices, and the R-domain, which is 
characterised by the presence of antiparallel β sheets (Turk et al, 1998; Turk et al, 
2012). The catalytic triad along with the residues that define the substrate binding site 
are situated between the L and R domains (Turk et al, 1998; Turk et al, 2012). The 
catalytic triad forms the catalytic site and is composed of cysteine, histidine and 
asparagine (Cys-25, His-159 and Asn-17) residues which are highly conserved amongst 
papain-like cysteine proteases (Turk et al, 1998; Turk et al, 2012). The Cys-25 and His-










Figure 1.3: A ribbon representation for a cysteine protease from the papain family. The 
catalytic triad, shown in ball and stick, is located between the L-domain and the R-domain. 




1.3.1. Inhibitors of Papain 
Papain is inhibited by antipain, chymostatin, L-transepoxysuccinyl-4-guanidinobutane 
(E-64), leupeptin, tosyl lysyl chloromethyl ketone (TLCK) and tosyl phenylalanyl 
chloromethyl ketone (TPCK) (Klein and Kirsch, 1969; Tomkinson et al, 1992; Farady 
and Craik, 2010). L-transepoxysuccinyl-4-guanidinobutane was first isolated from 
Aspergillus japonicus and has been proven to be a potent irreversible inhibitor of many 
cysteine proteases by binding to the Sn (n = 1~3) subsites of the papain family of 
cysteine proteases (Matsumoto et al, 1999; Varughese et al, 1989). The L-trans-
epoxysuccinic acid of E-64 is crucial for inhibition as the C-2 atom of the epoxy ring 
reacts with the Cys-25 of papain and papain like cysteine proteases (Varughese et al, 
1989). This irreversible binding occurs with the active thiol group of many cysteine 
proteases but will not react with the functional thiol group of non-protease enzymes. 
Leupeptin, TLCK and TPCK are broad spectrum inhibitors and inhibit cysteine and 
also serine proteases (Matsumoto et al, 1999; Farady and Craik, 2010).  
 
1.3.2. Applications and uses of Papain  
Papain has been investigated in different biotechnology processes and has found 
application particularly in the food and medical industry (Amri and Mamboya, 2012). 
The protease was first used as a natural remedy to heal wounds without harmful effects 
(Flindt, 1979). Papain has also been used in the drug discovery sector due to similarities 
in structure with cathepsin L proteases (Amri and Mamboya, 2012) which has allowed 
papain to act as a model enzyme for the design of specific cathepsin L inhibitors (Amri 
and Mamboya, 2012). In the food industry, papain has become a key ingredient in meat 
tenderisers, is a common ingredient in the brewery industry and papain has also been 
used in the confectionary, dairy, textile and tanning industries (Amri and Mamboya; 
Chaplins, 2002; Lambri et al, 2014).  
 
1.4. A cysteine protease from Trypanosoma congolense (TcoCATL) 
Congopain (TcoCATL) is a 33 kDa cysteine protease that was first purified from 
bloodstream forms of Trypanosoma congolense by monoclonal antibody affinity 
chromatography (Authié et al, 1992) and validated by N-terminal sequencing. The 
protein was subsequently expressed in Escherichia coli and in a baculovirus system, 
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however, the bacterial system yielded an expressed protein which was incorrectly 
folded and inactive while the baculovirus system gave a poor yield of protein (a 
maximum of 1 mg per 1L of culture supernatant) (Boulangé et al, 2001). Numerous 
other expression systems were tested due to these challenges and it was shown by 
Boulangé and co-workers that using the methylotrophic yeast Pichia pastoris as an 
expression system yielded high levels of the protein (Boulangé et al, 2011). The 
recombinant full length and catalytic domain expressed in P. pastoris showed unusual 
dimerisation of the recombinant protein at a neutral pH (Boulangé et al, 2011). The 
recombinant catalytic domain of congopain (TcoCATLcat) appeared as a dimer with an 
apparent size of 40 kDa under neutral pH conditions, however, once incubated at an 
acidic pH reverted to a monomer with an apparent size of 26 kDa (Boulangé et al, 
2011).   
 
TcoCATL is a member of the papain family of cysteine proteases and has been 
identified as a cathepsin L-like enzyme. The protease is expressed as a 444 amino acid 
long protein which is composed of a signal peptide of 20 amino acid residues, a 
propeptide region of 105 amino acids, a catalytic domain of 215 amino acids and a 
unique C-terminal extension of 104 amino acids (Boulangé et al, 2001). The propeptide 
region contains an inhibitory domain of 56 amino acids which controls proteolytic 
activity by blocking the active site during the folding of the protein (Lalmanach et al, 
1998). This propeptide region is also responsible for the production of mature protein. 
The C-terminal extension is linked to the catalytic domain by a proline-rich hinge 
region (Huson et al, 2009). This C-terminal extension has been found to occur in other 
trypanosomal cysteine proteases such as cruzipain from T. cruzi (TcrCATL), however, 
it has not been observed in mammalian cysteine proteases (Lalmanach et al, 1998; 
Boulangé et al, 2001; Huson et al, 2009).  
 
A homology-based model for TcoCATLcat was constructed by Lecaille et al (2001) due 
to the absence of a resolved crystal structure. Papain, actinidin, papaya protease omega 
and TcrCATL were used as template proteins for the construction of the homology 
model (Lecaille et al, 2001). A ribbon plot homology-based model for TcoCATLcat 
(Figure 1.4) reveals that the protein folds into two domains – a charateristic commonly 
exhibited by most cysteine proteases of the papain family (Lecaille et al, 2001; 




Figure 1.4: A homology model (ribbon representation) for TcoCATLcat based on using 
papain, actinidin, papaya protease omega and TcrCATL as template proteins. The 
catalytic domain of congopain is represented in grey and cruzain is represented in black. The 
proteins fold into two domains which are the L-domain and the R-domain. The model displays 
structural features which are similar to TcrCATL and can be accounted for by the 68% sequence 
identity that TcoCATL shares with TcrCATL in the catalytic domain. Taken from Lecaille et 
al, 2001. 
 
The homology model supported a hypothesis by Chagas et al (1997) wherein they 
postulated that TcoCATL would have a restricted specificity as compared to other 
papain like cysteine proteases due to the presence of leucine (Leu205, using papain 
numbering) at the bottom of the S2 subsite instead of a glutamic acid (Glu205, using 
papain numbering) residue that is present in TcrCATL (Lecaille et al, 2001). This 
substitution at position 205 can be observed in the homology-based model shown in 
Figure 1.5. The interdomain electrostatic interactions between the side chains of 
glutamic acid (Glu35 and Glu50, using papain numbering) and the positive charged 
lysine (Lys17 and Lys174, using papain numbering) residues have been conserved 
through evolution and this is observed in the 3D homology model constructed for 
TcoCATLcat. These interdomain electrostatic interactions are essential for the proper 






Figure 1.5: A homology-based model for the TcoCATLcat emphasising the S2 subsite 
substitution found in TcoCATL. The S2 subsite for TcoCATL is represented in grey with the 
S2 subsite of TcrCATL superimposed and displayed in black. The glutamic acid at position 205 
(papain numbering) for TcrCATL that is encircled in red is substituted by a leucine at position 
205 (papain numbering) for TcoCATL. Adapted from Lecaille et al, 2001. 
 
The substrate specificity of cathepsin L-like cysteine proteases is dependent on the P2 
subsites (Lecaille et al, 2001). Cysteine proteases of the papain family show an affinity 
for bulky hydrophobic residues such as phenylalanine in P2 and for arginyl residues in 
P1. This affinity for specific residues is due to the presence of a glutamic acid residue 
(Glu-205 in Figure 1.5) located at the bottom of the S2 subsite (Lecaille et al, 2001). 
This glutamic acid is substituted by a leucyl residue in TcoCATLcat. This substitution 
results in the affinity of phenylalanine in the P2 subsite but not an affinity for both 
phenylalanine and arginyl residues as observed with TcrCATL (Lecaille et al, 2001). 
The S2 subsite of TcoCATL has an amino acid composition that is remarkably similar 
to that of cathepsin K (Lecaille et al, 2001; Lalmanach et al, 2002). TcoCATL has a 
leucine at position 57 (papain numbering) which is not present in cathepsins L and B 
(Lecaille et al, 2001; Lalmanach et al, 2002). The leucine at position 57 in cathepsin K 
is responsible for the size restriction and depth of the S2 pocket which suggests its 
presence plays a similar role in TcoCATL and therefore may affect the S2 specificity 
(Lecaille et al, 2001; Lalmanach et al, 2002). TcoCATL, similarly to TcrCATL, is 
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activated by reducing agents such as L-cysteine, dithiothreitol (DTT) or β-
mercaptoethanol (β-Me) (Chagas et al, 1997). 
 
1.4.1. Inhibitors of TcoCATL 
TcoCATL is inhibited by E-64, cystatin, T-kininogens, leupeptin and peptidyl 
diazomethane which are common cathepsin L-like protease inhibitors (Chagas et al, 
1997; Lalmanach et al, 2002). In an attempt to generate novel inhibitors, Lalmanach 
and co-workers (Lalmanach et al, 1998) investigated the possibility of inhibiting 
congopain by using its prodomain. It was revealed, through this study, that peptides 
containing a 5-mer sequence YHNGA were competitive inhibitors for TcoCATL 
(Lalmanach et al, 1998). This YHNGA motif is highly conserved in trypanosomal 
cysteine proteases (Lalmanach et al, 1998; Lalmanach et al, 2002). 
 
1.4.2. Applications and uses of TcoCATL 
TcoCATL is the major lysosomal protease of Trypanosoma congolense, a parasite 
responsible for trypanosomiasis in livestock (nagana) and are mainly transmitted by the 
tsetse fly (Gitonga et al, 2017). Although the parasite has been known for more than a 
century, the control of the disease remains elusive as the current methods being utilised 
rely on vector control, chemoprophylaxis (Giordani et al, 2016) and chemotherapy 
(Sahin et al, 2014) which has been largely ineffective (Lalmanach et al, 2002).  
Observations made from inhibiting the activity of TcoCATL have led to TcoCATL 
being used as a target in vaccine development. Analysis of the two major domains of 
congopain have revealed that the C-terminal domain is the most antigenic but 
considered unlikely to produce antibodies which would inhibit enzyme activity 
(Lalmanach et al, 2002; Huson et al, 2009). The unique feature of the recombinant 
protein dimerising at a neutral pH may play a critical role in vaccine development given 
that the epitopes recognised by the sera of trypanosome-infected trypanotolerant cattle 
appear dimer-specific (Boulangé et al, 2001; Kateregga et al, 2012). 
 
1.5. Protein stability  
The linear chain of amino acids that is translated from mRNA by the ribosome forms a 
polypeptide or random coil. As translation and synthesis continues, the growing 
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polypeptide folds into a three-dimensional structure and ultimately assumes its native 
state (Dill, 1990; Magliery, 2015). The correctly folded structure, which can contain 
flexible random coil regions, is essential for function. Proteins in their native state can 
be unfolded by environmental changes in pH, temperature and ionic strength as well as 
through the introduction of chemical denaturants (Dill, 1990; Hinz et al, 1993; 
Magliery, 2015). The resulting unfolded or denatured protein is rendered biologically 
inactive.  
 
Protein stability refers to the net balance of forces that determine whether the protein 
exists within its active, native state or in its inactive, unfolded state. While electrostatic 
interactions, van der Waals forces and disulfide bonding contribute to the stability of a 
correctly-folded state of a globular protein, it is hydrophobic interactions and hydrogen 
bonding that contribute most (Dill, 1990; Pace, 1990; Moosavi-Movahedi et al, 2016). 
Analysis of the different forces that impart stability revealed that hydrophobic 
interactions contribute 50.8% and hydrogen bonding contribute 27.1% to overall 
protein stability while van der Waals forces, electrostatic interactions and disulphide 
bonding contribute 14.6%, 6.4% and 1.1% respectively (Pace, 1990). Data from the 
same study suggested that hydrophobic interactions provide the initial drive towards 
the folded state while the other forces then emerge to resist unfolding (Pace, 1990). The 
primary destabilising force, which acts to maintain the polypeptide in the unfolded 
state, is conformational entropy.  Each amino acid within a polypeptide can exist in a 
number of different conformations due to the rotation allowed around the bonds of the 
polypeptide backbone and the amino acid side-chain (Pace, 1990; Pace, 1992; Moosavi-
Movahedi et al, 2016). The multitude of possible conformations, and the coinciding 
loss of conformational entropy that would arise, decreases the likelihood that of a 
protein folding into a specific conformation.  
 
Under physiological conditions, the folding of most globular proteins is a reversible, 
two state process, between the folded and unfolded protein (Dill, 1990; Pace, 1990). 
Typically, the folding of the protein is thermodynamically favoured (i.e. ΔG < 0) and 
the destabilising force of conformational entropy, calculated to add ~7kJ/mol per amino 
acid residue to the reaction, is overcome by the accumulative contributions of the 
noncovalent interactions (Pace et al, 2009). By this thermodynamic definition, the 
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folding of the protein occurs spontaneously and, accordingly, the folded protein is more 
stable than any of the unfolded forms (Pace et al, 2009).    
 
1.5.1. Approaches to increase protein stability 
Proteins are extensively investigated for research, medical and industrial purposes. The 
folded state of the protein offers the most functionality and application and is therefore 
of most practical relevance and interest (van den Burg and Eijsink, 2002; Scott et al, 
2013). Despite the spontaneous nature of folding and the complexity of the three-
dimensional structure of the active protein, the folded state of a protein is only 
marginally more stable than the unfolded forms (Pace, 1990; Fu et al, 2010). For most 
proteins at physiological pH and temperature, the ΔG of folding, and therefore the net 
stability of a protein, falls within the range of – 20 to – 60 kJ/mol. This modest 
thermodynamic stability presents a common challenge for research and a general 
limitation to their industrial application. Substantial effort has therefore been directed 
towards increasing the net stability of the folded form of the protein to yield practical 
benefits of increased production yield, longer shelf-life and greater tolerance to 
environmental stresses (Pace et al, 2009; Fu et al, 2010). The most effective methods 
derived to date include the introduction of mutations, the manipulation of buffer 
conditions and the use of small molecular weight ligands as will be explained in the 
following sections.    
 
1.5.2. Mutations 
Altering the protein primary structure is a well-documented approach aimed at 
increasing stability (Scott et al, 2013; Magliery, 2015). A plethora of computational 
tools have been developed to predict the effect of mutations (including established tools 
such as Protherm, Rossetta and FoldX) and facilitate experimental methods such as site-
specific mutations and random point mutations (Gromiha et al, 1999; Gromiha, 2007). 
Efforts to increase stability in this manner have proven challenging with low success 
rates. As measured through phenotypic functionality assays, random substitutions are 
estimated to yield stabilising mutations in < 2% of cases (Broom et al, 2017). 
Computational tools largely avoid functional residues; however, the over-emphasis 
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towards increasing surface hydrophobicity typically generates stabilised proteins with 
poor solubility profiles (Broom et al, 2017).   
 
1.5.3. Buffer composition 
The manipulation of buffer conditions is a widely accepted and extensively used 
method to increase protein stability. Arguably the most common condition that can 
affect protein stability is the pH of the solution (Yang and Honig, 1993). The 
concentration of the H+ ions present in a solution affects the charge of the amino acid 
side chains and, consequently, the interactions that these side chains are involved in 
(Yang and Honig, 1993). Accordingly, protein folding and stability is largely pH 
dependent and typically follows a bell-shaped curve with either a single stability 
maximum or multiple stability maxima across a pH range. Prior studies have also 
established that the pH optima for stability is correlated with the pH optima for activity 
(Talley and Alexov, 2010). Equally, ionic species have been observed to impact protein 
stability at physiological concentrations (i.e. 1 to 200 mM). Although not precisely 
defined, it is accepted that ionic species affect protein stability through multiple, 
complex, mechanisms. In the predominate mechanism, increasing salt concentration 
induces point charges on the protein that yields unfavourable, repulsive forces between 
the medium (i.e. the buffer solution) and the protein leading to aggregation and 
precipitation (i.e. the principle behind ‘salting-out’) (Talley and Alexov, 2010; Vedadi 
et al, 2006). As the correctly folded protein has less surface area than the unfolded 
forms, the increase in salt concentration (salting out) destabilises the unfolded forms to 
a greater extent than the folded protein. As per the thermodynamic equation of stability, 
this action leads to a net increase in stability of the folded protein over the unfolded 
forms. Additionally, the increase in salt ions is also known to increase the hydrophobic 
effect (Thomas et al, 2002) and solvation energy; both of which contribute towards 
increasing the net stability of a folded protein.  
 
1.5.4. Ligands 
As a characteristic paradigm of drug discovery, small-molecule ligands bind to proteins 
in order to inhibit the protein’s activity (especially in the case of enzymes and 
receptors), activate the protein (i.e. the activation of membrane receptors) or disrupt the 
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interaction of a protein with another protein or in a complex (as in the case of protein-
protein interaction inhibitors) (Celej et al, 2003; Waldron and Murphy, 2003). Over the 
past two decades, it has been conclusively determined that when ligands bind to a 
protein, they also effectively increase the net stability of that protein. In binding, ligands 
reduce the inherent flexibility of a protein and decrease the surface area of the protein 
exposed to solvent. Taken together, these actions reduce conformational entropy (the 
force favouring unfolding) and decrease the Gibbs free energy of the ligand – protein 
complex (Celej et al, 2003; Waldron and Murphy, 2003). As such, when a ligand binds 
preferentially to a folded protein it yields a net increase in stability of the folded protein 
over the unfolded forms. Equally, ligands bind to and stabilise unfolded forms of the 
protein. Ligands that bind preferentially to an unfolded form of a protein, shift the 
equilibrium away from the folded protein thereby establishing the unfolded form of the 
protein as the dominate species within the solution (New et al, 2014). In theory, ligands 
may bind equally to both the folded and unfolded forms of a protein; however, in 
practice it has been observed that the high affinity binding to the folded protein is 
thermodynamically favoured over the multiple, low affinity binding to the unfolded 
forms (Waldron and Murphy, 2003).  
 
1.6.  Techniques used to determine protein stability 
Stabilisation of a protein has numerous practical purposes. Amongst others, protein 
stabilisation facilitates expression, purification and storage as stabilised proteins are of 
higher homogeneity and less likely to unfold, aggregate or succumb to proteolysis 
(Bloom et al, 2006). Similarly, a more stable protein holds increased value as an 
immunogen as immune responses to aggregates and unfolded forms of the protein are 
diminished (Rantanji et al, 2014; Scheiblhofer et al, 2017). The higher yields, increased 
homogeneity and reduced flexibility induced through protein stabilisation have also 
significantly improved the likelihood of successful protein crystallisation (Bloom et al, 
2006; Chen et al, 2008). Finally, as protein stability is often a consequence of ligand 
binding, this measure has been utilised effectively in drug discovery efforts to identify 
ligands and characterise binding. A large number of experimental techniques based on 
the principles of, amongst others, Fourier transform infrared (FTIR) spectroscopy, 
nuclear magnetic resonance (NMR), circular dichroism (CD) spectroscopy, differential 
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scanning calorimetry (DSC) and differential scanning fluorometry (DSF) have 
subsequently been designed to determine protein stability.  
 
Fourier transform infrared spectroscopy is an improvement on infrared (IR) 
spectroscopy, which is one of the oldest and well-established techniques used primarily 
for structural studies (Kong and Yu, 2007). The method is defined as a measurement of 
wavelength and intensity of the absorption of IR radiation by a sample (Dzwolak et al, 
2002). The IR radiation of a sample is interpreted by vibrations of a structural repeat 
unit (Garidel and Schott, 2006). The polypeptide and protein repeat units give rise to 
nine characteristic IR absorption bands which are then analysed to determine the 
secondary structure of the protein (Kong and Yu, 2007). Fourier transformed infrared 
spectroscopy has been used successfully to determine the secondary structure of 
proteins along with any conformational changes (due to ligand binding, temperature, 
pH and pressure changes), structural stability and aggregation of proteins (Kong and 
Yu, 2007). The structural stability of proteins are determined by measuring the amide I 
band position as a function of the temperature as the transitions of the proteins are 
observed over a temperature range (Fernandez-Ballester et al, 1992; Paolini et al, 
1999). The stability of porcine odorant-binding protein (OBP-I) in the presence and 
absence of ligands is observed in Figure 1.6. The shift of both transitions observed for 
samples of OBP-I with 2-isobuthyl-3-methoxypyrazine and 3,7-dimethyl-1-octanol 






Figure 1.6: Thermal denaturation curves for porcine odorant-binding protein (OBP-I) in 
the presence and absence of ligands. There are two transitions observed in the plot for all of 
the samples. The first is a slight decrease which is followed by a steady increase in the amide I 
band position. The samples are: ● OBP-I, ∆ OBP-I with the addition of an odorant (ligand) that 
has no affinity for OBP-I, □ OBP-1 with the addition of 2-isobuthyl-3-methoxypyrazine and ○ 
OBP-1 with the addition of 3,7-dimethyl-1-octanol. Taken from Paolini et al, 1999. 
● OBP-I 
∆ OBP-I + an odorant (ligand) 
that has no affinity for OBP-I 
□ OBP-1 + 2-isobuthyl-3-
methoxypyrazine 




Raman spectroscopy was discovered in 1928 by Sir C.V Raman and K.S. Krishnan 
when they observed the inelastic light scattering of molecules (Wen, 2007). Raman 
spectroscopy has been used for decades in academic environments to depict secondary 
and tertiary structure conformations of proteins’ by using laser-based technology (de la 
Cuesta et al, 2014). Raman spectroscopy accomplishes this in the same manner as FTIR 
as it detects molecular vibrations. These molecular vibrations of the polypeptide 
backbone of a protein sample are used to determine positions and intensities of amide 
bands which provide estimations of the secondary structure of a protein (Tuma, 2005; 
Bunaciu et al, 2015). The amide bands are further analysed using methods such as 
spectral decompositions or simplifying the complex and broad envelopes into 
component bands to generate more detailed information of the secondary structure 
(Bunaciu et al, 2015). The decomposed bands are then related to a set of reference 
spectra collected from proteins with defined three-dimensional structures and 
secondary structures (Bunaciu et al, 2015). A change in the secondary structure of a 
protein occurs due to denaturation, misfolding and aggregation and this technique is 
capable of characterising these changes in protein structure (Wen, 2007).  
 
Nuclear magnetic resonance is a powerful tool used for the analysis of protein structure 
and function and has been the basis for approximately 8300 derived protein structures 
being deposited into the Protein Data Bank by the year 2011 (Kwan et al, 2011). This 
technique is also very useful for studying protein-ligand interactions and protein 
dynamics (Li and Kang, 2017). Nuclear magnetic resonance spectroscopy is similar to 
the other forms of spectroscopy described here as the spectra are determined by 
observing changes between different energy states created by atomic nuclei found in 
the protein (Keeler, 2002; Kwan et al, 2011). The atomic nuclei of many isotopes such 
as 1H, 13C and 15N carry magnetic dipoles. These dipoles have different orientations and 
this property has been termed as the “spin” of the nuclei (Keeler, 2002). A key principle 
of NMR spectroscopy is the fact that the atomic nuclei have a nuclear spin and the 
nuclei are characterised by a nuclear spin quantum number (Keeler, 2002). The spin 
quantum number reveals the energy levels that will be generated when the nuclei are 
exposed to a magnetic field (Keeler, 2002). An NMR spectrometer is equipped with a 
powerful magnet capable of generating a magnetic field and then records the NMR 
signal of the atomic nuclei based on their dipole orientation or spin (Kwan et al, 2011). 
A plot of NMR signal intensity against resonance frequency is the simplest of NMR 
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spectra that can be detected and is defined as a one-dimensional (1D) NMR spectrum 
(Kwan et al, 2011). Two of the most useful and sensitive NMR spectra are the 1D 1H-
NMR spectrum (this spectrum determines the signal for the hydrogen protons in the 
protein) and 2D 15N-HSQC (heteronuclear single quantum coherent) spectrum which 
shows a signal for each 1H-15N covalently bonded group (Hoffman et al, 2005). A series 
of 1D 1H-NMR spectra over a long period of time can determine the stability of a 
protein when it is exposed to different factors such as pH, ionic strength or temperature. 
The unfolding of the protein is observed by the appearance of new signals in the central 
part of the spectrum (Shulman et al, 1997; Hoffman et al, 2005; Kwan et al, 2011). 
This degradation and increase in signal intensity can be observed for human α-
lactalbumin in Figure 1.7 as the concentration of urea increases from panel a to panel d 
which causes the protein to unfold (Shulman et al, 1997). 
 
Figure 1.7: The progressive appearance of unfolded human α-lactalbumin as the number 
of NMR signals increase with an increase in urea concentration from panel a-d. 2D 15N-
HSQC spectra shown for human α-lactalbumin in (a) absence of urea at 20°C; (b) 3 M urea at 
20°C; (c) 6 M urea at 20°C and  (d) 10 M urea at 20°C. The signals are labelled with their 
residue assignment as they become visible in the spectra. Taken from Shulman et al, 1997. 
 
Circular dichroism spectroscopy can be used to determine the secondary and tertiary 
structure of proteins in solution due to its ability to identify and quantify the proportion 
of α-helical, β-sheet and unordered conformations of a protein sample (Li et al, 2011). 
The technique has also been widely used for the evaluation of the stability and 
conformation of a protein under different environmental conditions such as ionic 
strength, pH and the addition of ligands (Correa and Ramos, 2009). Circular dichroism 
relies on the interaction between a source of circularly polarised light and a protein and 
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that protein’s ability to differentially absorb clockwise (right handed) or counter-
clockwise (left handed) circularly polarised light components of a plane-polarised wave 
(Kelly and Price, 2000). A CD instrument can measure the difference in absorbance 
between the left and right handed circularly polarised light components (Kelly and 
Price, 2000; van Mierlo and Steensma, 2000). This signal can also be represented as 
ellipticity (Kelly and Price, 2000; van Mierlo and Steensma, 2000). The method can 
successfully examine the secondary structure of a protein because the peptide bond is 
asymmetric and thus show the phenomenon CD. The CD spectra obtained for a protein 
is then compared to characteristic CD spectra of a folded protein to determine the 
secondary structure (Kelly and Price, 2000; van Mierlo and Steensma, 2000; Li et al, 
2011). The ellipticity observed at 222 nm is correlated with the α-helical content of a 
protein and is an example of characteristic CD spectra (Van Mierlo and Steensma, 
2000). Proteins which are folded in their correct state often have asymmetric secondary 
structural elements such as α-helices and β-sheets (van Mierlo and Steensma, 2000; 
Greenfield, 2006). When proteins begin to unfold, they lose these secondary structural 
elements and their CD bands change. As a function of temperature these changes in CD 
bands under characteristic wavelengths can be used to determine the thermal stability 
of the protein (Greenfield, 2006).    
 
Differential scanning calorimetry (DSC) has been reported as one of the most 
frequently used techniques in determining the thermal stability of a protein due to it 
being a label free technique (Huynh and Partch, 2016). A calorimeter measures the heat 
entering a sample or the heat exiting a sample. The technique incorporates the use of a 
differential scanning calorimeter which measures the heat of a sample relative to a 
reference sample over a defined time and temperature profile (Chen and Oakley, 1995; 
Gill et al, 2014; Kodre et al, 2014). A basic DSC experiment requires a sample 
chamber/cell which contains the protein of interest in solution and a reference cell 
which contains only the solvent and serves as the control (Chen and Oakley, 1995; 
Kodre et al, 2014). The technique measures the difference in the heat required to 
maintain a sample’s temperature as close as possible to that of the reference sample as 
it is exposed to a range of defined temperatures over a specific time profile (Chen and 
Oakley, 1995). This measurement is reflected as the excess heat capacity (Cp) of the 
sample and is quantified in units of J/g or J/mol (Gill et al, 2014; Kodre et al, 2014). 
Changes in the Cp of a sample originate due to the forces which disrupt the protein’s 
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native structure (Gill et al, 2014). The ability to measure the Cp of a protein sample 
along a temperature gradient allows the determination of physical changes such as 
phase transitions that occur during exposure to heating or cooling conditions (Gill et al, 
2014). These phase transitions include melting, decomposition and crystallisation of a 
protein sample. Differential scanning calorimetry experiments are also capable of 
providing information on protein structure as the thermodynamic parameters obtained 
from DSC experiments are sensitive to the structural state of the protein. A graph of 
excess heat capacity against temperature may reveal the melting point of the sample as 
a peak or as a dip depending on the DSC equipment used (Figure 1.8). 
 
 
Figure 1.8: Differential scanning calorimetry (DSC) experiment for the two-state 
unfolding of a globular protein. The graph of excessive heat capacity against a temperature 
range is plotted from measurements taken by the calorimeter and the melting point (TM) is 
depicted as the highest point i.e. the greatest heat capacity observed for the run. Taken from 
Bruylants et al, 2005. 
 
1.6.1. Thermal shift assay  
The TSA, which is also known as thermal scanning (Lavinder et al, 2009) or differential 
scanning fluorometry (DSF, Niesen et al, 2007), was first described by Pantoliano and 
co-workers as a technique that could aid in drug discovery (Pantoliano et al, 2001) and 
is seen as an improvement of the DSC technique (Reinhard et al, 2012; Vivoli et al, 
2014; Bruce et al, 2019). The TSA is a method which incorporates the use of 
environmentally safe dyes, which bind specifically to the hydrophobic regions of a 
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protein, and a real-time polymerase chain reaction (RT-PCR) machine which creates a 
temperature profile and records the fluorescence emitted by the dye. The dyes which 
are commonly used in TSA are highly fluorescent in non-polar environments such as 
the hydrophobic regions of an unfolded protein as compared to aqueous solutions where 
the fluorescence of the dye is quenched (Niesen et al, 2007). The RT-PCR machine 
therefore measures fluorescence of the dye as it binds to the hydrophobic regions of the 
protein. These hydrophobic regions are typically not exposed in the protein’s native 
conformation and thus the dye is unable to bind. As the temperature increases these 
hydrophobic regions become exposed due to unfolding or denaturation of the protein. 
The assay allows for the determination of the temperature at which the ΔGu of the 
protein reaches zero and this temperature will reflect the melting point of the protein. 
The point at which the ΔGu reaches zero for hen egg-white lysozyme at two different 
concentrations can be observed in Figure 1.9. This graph shows that the concentration 
of the protein does not affect the melting point of the protein as there is no difference 
in the melting point obtained. However, as can be seen, an increase in fluorescence is 
observed in response to an increase in concentration. 
 
 
Figure 1.9: Melt curve plot of hen egg-white lysozyme at two different concentrations. The 
plot depicts the fluorescence obtained for samples of hen egg-white lysozyme during a 
temperature gradient in Kelvin. Each of the concentrations were run in duplicate. The red line 
indicates the hen egg-white lysozyme at a concentration of 1 mg/ml and the blue line indicates 
the hen egg-white lysozyme at a concentration of 2 mg/ml. The arrow indicates the melting 








The data used to construct a melt curve as in Figure 1.9 is a measure of the real time 
fluorescence obtained at a specific temperature. To identify the melting point, it is 
necessary to determine the temperature at which there are equal quantities of folded and 
unfolded protein. This is referred to as the inflection point and is represented by the 
midpoint of the slope. However, this point is not easily visible on the graph and can 
lead to improper interpretation of data. There are two ways to calculate the melting 
point based on the data obtained from the melt curve. The first method utilises the 
Boltzmann equation,  
              , where 
             y is the fluorescence intensity at temperature x, 
             LL represents the minimum intensity observed, 
             UL represents the maximum intensity observed and 
            a denotes the slope of the curve within TM (Ericsson et al, 2006). 
 
The second method is the simpler of the two and can be performed by normalising the 
data from the melt curve and this is achieved by calculating the first derivative of the 
data. The melting point of the protein of interest is then determined by identifying the 
maximum first derivative point (Niesen et al, 2007). An example of the derivative graph 




Figure 1.10: Derivate plot of hen egg-white lysozyme at two different concentrations.  The 
plot depicts the first derivative for the raw fluorescence obtained for samples of hen egg-white 
lysozyme during a temperature gradient in Kelvin. The arrow indicates the melting point 
observed for the protein and is represented by the peaks of the derivative curve. The melting 
point for the derivative curve is 348 K which was the same melting temperature determined by 




Numerous factors which can affect protein stability such as pH, salt concentration, 
aggregation, mutation and ligand binding can be studied using the thermal shift assay 
(Huynh and Partch, 2016; Miyazaki et al, 2017; Bruce et al, 2019). The method aids in 
determining the optimum conditions such as pH and ligand interaction that can increase 
the TM of the protein thus causing the protein to become more stable. The principle of 
whether a ligand can increase stability of a protein and the detection thereof using the 
thermal shift assay is shown in Figure 1.11 where there is a shift observed in the melt 







Figure 1.11: The increase in stability of a protein due to ligand-protein interaction, as 
detected through the thermal shift assay. (A) depicts how SYPRO Orange binds to a protein 
as the hydrophobic regions become exposed and (B) shows the addition of a ligand will cause 
the protein to become more stable and thus the protein starts unfolding at a higher temperature. 
Qiagen-Literature: News, 2010. 
 
The ability to study the effect of more than one factor at a time on protein stability has 
been a limitation for many of the previously described techniques, however, TSA does 
not share this limitation (Ericsson et al, 2006; Niesen et al, 2007; Ragoonanan and 
Aksan, 2007). The technique can be used to monitor the stability of a protein in the 
presence of numerous buffers and can also be used to monitor the effect of introducing 
a ligand on protein stability. Thus, the technique is able to determine the combined 
effect of a range of buffers and ligands on protein stability (Eriksson et al, 2006; Niesen 
et al, 2007; Ragoonanan and Aksan, 2007; New et al, 2014; Miyazaki et al, 2017). An 
example of this combined screening can be observed in Figure 1.12. The TSA has a 
number of advantages over previously described methods as this method does not 
require a significantly large quantity of protein sample, the method does not require 
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numerous expensive reagents and the time required for data acquisition is drastically 
reduced (Niesen et al, 2007; Ragoonanan and Aksan, 2007; Huynh and Partch, 2016). 
 
Figure 1.12: Melt curve plot for porcine citrate synthase (1 µM) screened against three 
different buffers in the presence and absence of 100 µM oxaloacetate. The graph shows the 
melt curve plot of porcine citrate synthase in NaAc buffer (pH 5.0) represented by a blue line 
without 100 µM oxaloacetate and by a purple line in the presence of 100 µM oxaloacetate, 
HEPES buffer (pH 7.5) represented in green without 100 µM oxaloacetate and by an aqua line 
in the presence of 100 µM oxaloacetate and BORAX buffer (pH 9.0) represented by a yellow 
line without 100 µM oxaloacetate and by a red line in the presence of 100 µM oxaloacetate. 
Taken from Niesen et al, 2007. 
 
1.7.  Hypothesis, Aims and Objectives of the study 
The hypothesis of this study proposes that cysteine proteases can be stabilised through 
the manipulation of buffer and/or ligand conditions. The aim of this study was, 
therefore, to deduce the precise experimental conditions that would favour and enhance 
the stabilisation of two representative cysteine proteases; namely papain and the 
catalytic domain of congopain. To this end, protein thermal stability was selected as the 
means to determine the extent of stabilisation conferred by the conditions evaluated. To 
realise this aim, the following objectives were defined and undertaken:  
 
1) Assessment of the suitability of papain and congopain for use in thermal stability 
assays. 
2) Determination of the thermal stability of the two selected cysteine proteases under 
standard conditions. 
3) Comparative evaluation of experimental conditions and the identification of factors 
that stabilise the two cysteine proteases.   
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2. MATERIALS AND METHODS 
2.1.  Materials 
2.1.1. Expression of recombinant TcoCATLcat 
The catalytic domain of congopain in pPIC9 (TcoCATLcat) (Pillay, 2010) was sourced 
from previous transformations performed in our laboratory. Yeast extract, peptone, 
glucose, tetracycline, ampicillin, bacteriological agar, yeast nitrogen base without 
amino acids, glycerol, biotin and Whatman #4 filter paper were purchased from Sigma-
Aldrich (USA). Buffer salts and other common chemicals were purchased from Sigma-
Aldrich (USA) and Merck (Germany). 
2.1.2. Analysis of expressed TcoCATLcat 
Bovine serum albumin (BSA) and Bradford reagent stock were obtained from Sigma-
Aldrich (USA). The TGX FastCast Kit and the Precision Plus protein standard were 
purchased from BioRad (USA). SDS-PAGE reagents using the Laemmli system and 
staining reagents were purchased from Sigma-Aldrich (USA) and Merck (Germany). 
Papain from papaya latex was obtained from Sigma-Aldrich (USA). The SeeBlue Plus2 
pre-stained protein was obtained from ThermoFisher Scientific (USA) and BioTrace 
polyvinylidene fluoride transfer (PVDF) membrane was purchased from PALL Corp 
(USA). The low-fat milk powder was purchased from Sigma-Aldrich (USA). The 
affinity purified chicken anti-TcoCATLcat IgY primary antibody was previously 
prepared in our lab (Pillay, 2010). Goat-anti-chickenn IgY (IgG) (H + L), horseradish 
peroxidase enzyme (HRP) conjugate and the WesternBright ECL chemiluminescent 
HRP substrate were purchased from Advansta (USA). 
2.1.3. Stability determination via thermal shift assay 
The Protein Thermal ShiftTM Starter Kit and SYPRO orange dye were purchased from 
ThermoFisher Scientific (USA). The extra clear PCR tubes were obtained from 
Whitehead Scientific (USA). E-64 and chymostatin were obtained from Sigma-Aldrich 
(USA). A total of 50 compounds was extracted from the DIVERSet ChemBridge 
Library of compounds and obtained from ChemBridge Corp (USA). Buffer salts and 







2.2.1. Analysis of the amino acid sequence for papain and the catalytic domain of 
TcoCATL. 
The UniProt protein database (https://www.uniprot.org/) was used for obtaining the 
amino acid sequence for papain (accession number: P00784) and TcoCATLcat 
(accession number: Q26895) and was further used to predict the overall hydrophobicity 
and the theoretical melting temperature of each protein. The Kyte-Doolittle 
hydrophobicity plot was generated using the online tool available at the Expert Protein 
Analysis System (ExPASy) Bioinformatics Resource portal (www.expasy.org). The 
amino acid sequence for papain was pasted into the ProtScale tool and the Kyte-
Doolittle hydrophobicity plot was selected as the desired output. The parameters for the 
plot were set to default with a window size of 9, the relative weight of the window 
edges compared to the window centre set to 100%, the weight variation model set to 
linear while the option to normalise the scale from 0 to 1 was not selected. This 
sequence of steps was repeated for TcoCATLcat. 
 
A hydrophobicity cluster analysis (HCA) was generated using the HCA v1.0.2. tool 
available at the Ressource Parisienne en BioInformatique Structurale (RPBS) portal 
(http://mobyle.rpbs.univ-paris-diderot.fr/cgi-bin/portal.py?form=HCA#forms::HCA). 
A helical wheel was generated via the online helical wheel projection tool available at 
http://heliquest.ipmc.cnrs.fr/. The sequence of each protein was inserted into the 
designated window and the parameters were then set. The helix type was set to alpha 
helix and the option to have one letter code size proportional to amino acid volume was 
not selected. The window size was set to full, allowing for a maximum of three rotations 
for the helical wheel output while the rotation of the helix to align vertically to the 
<µH> vector was not selected. The helical wheel generated was saved as an image and 
was analysed by using the index available via the helical wheel tool. A theoretical 
melting point was generated using the online tool available at 
http://tm.life.nthu.edu.tw/. The amino acid sequence was inserted in the window and 
submitted for analysis. The tool then generated an index value with its associated 





2.2.2. Recombinant expression of the catalytic domain of TcoCATL from T. 
congolense 
The catalytic domain of TcoCATL had previously been cloned into a pPIC 9 yeast 
expression vector and transformed into GS115 yeast cells in the laboratory (Pillay et al, 
2010). Glycerol stocks of these transformed cells were used for the expression of 
TcoCATLcat. Briefly, the glycerol stock was streaked onto yeast extract peptone 
dextrose (YPD) plates [10% (w/v) 10x yeast extract peptone (YP), 5% (w/v) 2 M 
glucose, 10 µg/ml tetracycline (Sigma-Aldrich, USA), 50 µg/ml ampicillin, 2% 
bacteriological agar) and the plates were incubated at 30°C for 72 hours. A single 
colony was selected from the plate and inoculated into YPD broth [10% (w/v) 10x YP, 
5% (w/v) 2 M glucose, 10 µg/ml tetracycline, 50 µg/ml ampicillin]. The inoculated 
YPD broth was incubated in baffled flasks at 30°C with agitation (200 rpm) for 48 
hours. The culture in YPD broth was transferred to buffered medium glycerol yeast 
[BMGY, 100 mM potassium phosphate buffer, pH 6.5, 1.34% (w/v) yeast nitrogen base 
without amino acids (Sigma-Aldrich, USA), 10% (w/v) 10x YP, 50% glycerol, 
0.0004% (w/v) biotin (Sigma-Aldrich, USA), 10 µg/ml tetracycline and 50 µg/ml 
ampicillin] in a 1:9 ratio and was grown at 30°C for 72 hours with agitation.  
 
The culture was centrifuged at 2000 x g for 10 minutes at 4°C. The pellet was 
resuspended in buffered minimal medium [BMM, 100 mM potassium phosphate buffer, 
pH 6.5, 1.34% (w/v) yeast nitrogen base without amino acids, 0.0004% (w/v) biotin, 
10 µg/ml tetracycline, 50 µg/ml ampicillin] and the supernatant was discarded. The 
resuspended cells were transferred into baffled flasks and covered with three layers of 
sterile cheesecloth to promote aeration. The first round of expression of the recombinant 
protein was achieved over the duration of a 7-day incubation at 30°C with agitation 
(200 rpm) and induction by the addition of 0.5% (v/v) methanol daily.  The samples 
were centrifuged at 2000 x g for 10 minutes at 4°C as before however the supernatant 
containing the expressed protein was collected. The pellet was resuspended in BMM as 
before, transferred into baffled flasks and a second round of expression done exactly as 
the first round. 
 
The supernatant containing the expressed protein was collected as described. The 
recombinant TcoCATLcat in the supernatant collected from both rounds of expression 
was isolated using three phase partitioning (TPP) (Dennison and Lovrien, 1997). The 
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supernatant was filtered through Whatman #4 filter paper, before tertiary butanol was 
added to the filtered supernatant at a 30% (v/v) final concentration. To this mixture, 
ammonium sulfate was added at a 30% (w/v) final concentration and mixed until it had 
entirely dissolved. The resulting mixture was centrifuged at 6000 x g at 4°C for 10 
minutes. The centrifugation resulted in the formation of three phases. The protein 
precipitate layer formed in the middle and therefore the upper tertiary butanol layer and 
aqueous bottom layer were removed. The protein precipitate was resuspended in the 
least amount of phosphate buffered saline (PBS), pH 7.2 and thereafter aliquoted into 
2 ml microtubes. 
 
2.2.3. Analysis of expressed TcoCATLcat 
2.2.3.1. Determination of protein concentration using the Bradford assay 
A Bovine serum albumin (BSA, Sigma-Aldrich, USA) solution (1 mg/ml) was used for 
the generation of the standard curve. A two-fold serial dilution was performed to obtain 
five concentrations of BSA that would be tested from 0.03125 to 0.5 mg/ml working 
concentration. The Bradford reagent stock (Sigma-Aldrich, USA) was used in a 9:1 
ratio. The samples were incubated at room temperature for 5 minutes and absorbance 
was measured at 595 nm using a Biowave DNA WPA V1.8.0 spectrophotometer. The 
data was collected using the Resolution V2.4.5.0 program. A standard curve was 
produced by plotting the average absorbance of the samples against concentration and 
the expressed TcoCATLcat samples concentrations were derived from the standard 
curve. 
 
Figure 2.1: Standard curve for the Bradford protein assay. Bovine serum albumin standards 
ranging from 0.03125 to 0.5 mg/ml were added to Bradford reagent and the resulting 
absorbance values measured at 595 nm after incubation at room temperature for 5 minutes. The 































2.2.3.2. Determination of the molecular weight of the expressed protein using 
reducing and non-reducing SDS-PAGE 
FastCast acrylamide gels (12%) were prepared using the TGX FastCast Kit (BioRad, 
USA) as per the manufacturer’s instructions. The TGX FastCast gels were loaded with 
5 µl of the expressed TcoCATLcat mixed with either 5 µl of reducing [125 mM Tris-
HCL, 4% (w/v) SDS, 20% (v/v) glycerol, 10% (v/v) 2-mercaptoethanol, pH 6.8] or 
non-reducing sample buffer [125 mM Tris-HCL, 4% (w/v) SDS, 20% (v/v) glycerol, 
pH 6.8]. The samples containing the reducing sample buffer were placed in a boiling 
water bath for 90 seconds prior to being loaded onto the gel. The Precision Plus protein 
standard (BioRad, USA) was used as a molecular weight marker for the gels. 
Electrophoresis was conducted at 20 mA per gel for approximately 90 minutes. The gel 
was thereafter stained in Coomassie blue R-250 staining solution [0.025% Coomassie 
Brilliant blue R-250, 40% methanol, 7% glacial acetic acid] overnight. The stain was 
discarded, and the gel was placed in Destaining Solution 1 [40% methanol, 7% glacial 
acetic acid] for 30 minutes followed by Destaining Solution 2 [5% methanol, 7% glacial 
acetic acid] until background was visibly reduced. The gel image was captured using 
the SYNGENE G:BOX and analysed using the GeneSys V1.2.4.0 program. 
 
An SDS-PAGE was also performed using the Laemmli system (Laemmli, 1970) under 
reducing conditions. A 12.5% running gel was prepared with a 4% stacking gel 
(Laemmli, 1970). The gel was prepared in duplicate and these gels were loaded with 2 
µg of the expressed protein, 5 µg of papain from papaya latex (Sigma-Aldrich, USA) 
as a control and 2 µl of SeeBlue Plus2 pre-stained protein standard (ThermoFisher 
Scientific, USA) and run at 20 mA per gel for approximately 90 minutes. One gel was 
thereafter stained in Coomassie blue R-250 staining solution and destained as 
previously described. The gel image was captured using the SYNGENE G:BOX and 
analysed using the GeneSys V1.2.4.0 program. The duplicate gel was used for the 
western blot analysis. 
 
2.2.3.3. Confirmation of expressed protein as the catalytic domain of TcoCATL 
via western Blot 
The SDS-PAGE gel prepared as described in section 2.2.3.2 was placed into a electro-
transfer sandwich with the following components in order; a layer of Scotchbrite foam, 
two layers of Whatman No.4 filter paper, the SDS-PAGE gel, BioTrace polyvinylidene 
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fluoride transfer (PVDF) membrane (PALL Corp, USA), two layers of Whatman No.4 
filter paper, a layer of Scotchbrite foam. The SDS-PAGE gel was carefully placed onto 
the PVDF membrane to avoid any air bubbles. The sandwich was placed into a western 
blot tank, filled with blotting buffer and the blot was run at 40 mA for 16 hours. The 
gel was removed and stained using the Coomassie staining procedure as described in 
section 2.2.3.2 while the unoccupied sites on the PVDF membrane was blocked for 1 
hour using a 5% (w/v) low fat milk powder in tris buffered saline (TBS: 20 mM Tris, 
200 mM NaCl, pH 7.4). The membrane was washed in TBS (3 x 5 minutes), followed 
by a two-hour incubation with the affinity purified chicken-anti-TcoCATLcat IgY 
primary antibody (in-house preparation, Pillay et al, 2010) prepared in a 0.5% (w/v) 
BSA-TBS at a 10 000 x dilution. The membrane was washed in TBS (2 x 5 minutes) 
followed by a one hour incubation with the horseradish peroxidase enzyme (HRP)-
conjugated secondary antibody [goat-anti-chicken IgY (IgG) (H + L), HRP conjugate, 
Advansta, USA] prepared in 0.5% (w/v) BSA-TBS solution at a 40 000 x dilution. The 
membrane was washed in TBS (3 x 5 minutes) and incubated for two minutes in 
WesternBright ECL chemiluminescent HRP substrate (Advansta, USA). The image 
was captured using the SYNGENE G:BOX and analysed using the GeneSys V1.2.4.0 
program. 
 
2.2.3.4. Gelatin substrate containing SDS-PAGE zymogram 
The protocol for a standard SDS-PAGE gel was modified by incorporating 0.1% (w/v) 
gelatin substrate into the 12.5% running gel. Additionally, an overlay solution [0.05% 
(w/v) gelatin] was poured over the running gel and allowed to set and a standard 4% 
stacking gel was prepared. The gel was loaded with 2 µl of SeeBlue Plus2 pre-stained 
protein standard (ThermoFisher Scientific, USA) and recombinantly expressed 
TcoCATLcat was loaded in concentrations ranging from 0.01 µg/ul to 0.1 µg/µl. The gel 
was run at 20 mA per gel for approximately 90 minutes and soaked in two changes of 
2.5% (v/v) Triton X-100 at room temperature for 60 minutes to replace the SDS with 
Triton X-100 to restore proteolytic activity. The gel was incubated in assay buffer [PBS 
pH 7.4] at 37°C for 120 minutes. The gel was stained using 0.1% (w/v) amido black 
solution (amido black was dissolved in methanol: acetic acid: distilled water in the 
proportions 30:10:60) for 1 hour and destained by using a solution of methanol, acetic 
acid and distilled water (30:10:60). The gel was placed in several changes of destain 
solution until the clear areas of the proteolytic digestion of the dark stained gelatin were 
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visible. An image of the gel was captured using the SYNGENE G:BOX and analysed 
using the GeneSys V1.2.4.0 program. 
 
2.2.3.5.  Dimerisation of the catalytic domain of TcoCATL 
An SDS-PAGE was performed using the Laemmli system (Laemmli, 1970) under non-
reducing conditions. A 12.5% running gel was used with a 4% stacking gel. The 
catalytic domain of TcoCATL was loaded at 2 µg. Three buffers of different pH (4.5, 
7.4 and 8.0) were used. At each pH, the catalytic domain of TcoCATL sample was 
heated at 30°C, 60°C or 90°C for a period of 90 seconds. The gel was loaded with the 
prepared samples and 2 µl of SeeBlue Plus2 pre-stained protein standard 
(ThermoFisher Scientific, USA) and run at 20 mA per gel for approximately 90 
minutes. The gel was stained in Coomassie blue R-250 staining solution and destained 
as described in section 2.2.3.2. An image of the gel was captured using the SYNGENE 
G:BOX and analysed using the GeneSys V1.2.4.0 program. 
 
2.2.4. Control thermal shift assay using a Protein Thermal ShiftTM Starter Kit 
The Protein Thermal ShiftTM Starter Kit was used as per manufacturer’s instructions 
(ThermoFisher Scientific, USA). Briefly, test samples were prepared through the 
addition of control protein at a final concentration of 0.1 ug, followed by the control 
ligand at 0.1 mM or 1 mM and protein thermal shift buffer to an extra clear PCR tube 
(Whitehead Scientific, USA). Preparation of each sample was done on ice. The thermal 
shift dye was diluted in the protein thermal shift buffer and added at a final 
concentration of 8x directly before the tubes were loaded into the Rotor-GeneTM 6000 
2-Plex RT-PCR machine (Corbett Research, USA). The Rotor-GeneTM 6000 2-Plex 
RT-PCR machine was used in conjunction with the Rotor-GeneTM 6000 series software 
version 1.7 to analyse the data obtained for each run. The run conditions programmed 
for the experiment were to create a temperature profile between 25°C and 99°C with 
the temperature increasing by 0.1°C increments after a period of 2 seconds. At this 
point, the temperature was held in order to detect the fluorescence through the HRM 
channel using an emission wavelength at 460 nm and an excitation wavelength of 510 




2.2.5. Optimisation of the thermal shift assay 
Papain, at concentrations ranging from 0.08 to 0.4 µg/µl, was evaluated in conjunction 
with different SYPRO orange dye (ThermoFisher Scientific, USA) concentrations 
ranging from 10x to 40x diluted in PBS (pH 7.4). The run conditions designed for the 
optimisation experiments recorded fluorescence for a temperature profile between 25°C 
and 99°C with the temperature increasing by various increments, whereby the minimum 
tested was 0.1°C and the maximum increment tested was 0.5°C. A range of holding 
times were also tested where the minimum holding time tested was 1 second and the 
maximum tested was 5 seconds at each temperature point.  
 
2.2.6. Determining the stability of papain using the optimised thermal shift assay 
2.2.6.1.  Determining the effect of pH on the stability of papain 
Two separate buffer libraries were prepared to test the effect of pH on the stability of 
papain. The first buffer library was adapted from the buffer library of Reinhard et al 
(2012). The buffer library consisted of the following 50mM buffers: sodium citrate, pH 
4.0; sodium citrate, pH 5.0; sodium citrate, pH 5.5; sodium phosphate, pH 6.0; MES, 
pH 6.7; PIPES, pH 6.7; MOPS, pH 7; sodium phosphate, pH 7.0; PBS, pH 7.4; bicine, 
pH 8.0 and HEPES, pH 8.0. The second buffer library prepared made use of a single 
Acetate-MES-Tris (AMT) buffer (Ellis and Morrison, 1982). The buffer consisted of 
100 mM acetate, 100 mM MES and 200 mM Tris and 4 mM ethylenediaminetetraacetic 
acid (EDTA), and the pH adjusted to a pH range between 4.0 and 8.5 using HCl. The 
buffer libraries were tested on papain using the optimised TSA. The volume of each 
buffer, the concentration of papain (0.2 µg/µl) tested and the concentration of SYPRO 
orange dye (10X) were kept constant. The conditions for each run were set as per the 
optimised conditions determined as per section 2.2.5. The fluorescence was measured 
by using the HRM channel on the Rotor-Gene RT-PCR machine with the gain 
optimisation option selected. The temperature profile tested was set from 25°C to 99°C. 
The temperature was set to increase in 0.5°C increments with the holding time set to 5 
seconds. The data obtained was analysed using the Rotor-GeneTM 6000 series software 
version 1.7. 
 
2.2.6.2.  Determining the effect of ligand binding on the stability of papain 
The compound library consisting of 50 compounds was extracted from the DIVERSet 
ChemBridge Library of compounds (ChemBridge Corp, USA). The 50 compounds 
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were tested against papain along with chymostatin, an inhibitor for papain and other 
cysteine proteases. The compounds from the library were tested at a concentration of 
10 µM in PBS whilst chymostatin was tested at concentrations from 10 µM to 50 µM 
all in PBS, pH 7.2. The compounds were incubated with 0.2 µg/µl of papain and 10X 
SYPRO orange dye. The run conditions were set to create a temperature range from 
25°C to 99°C with the temperature set to increase in increments of 0.5°C after holding 
at each temperature point for 5 seconds. The data obtained from testing the compounds 
were thereafter analysed by using the Rotor-GeneTM 6000 series software version 1.7. 
 
2.2.6.3. Determining the combined effect of pH and ligand binding on the 
stability of papain 
The combination of applying a pH change and a ligand interaction with papain was then 
tested by using papain and the inhibitor, chymostatin, with a variety of different buffers. 
The buffers that were tested were sodium citrate at pH 4.0, pH 5.0, pH 5.5 and sodium 
phosphate pH 6.0. Papain (0.2 µg/µl), 10X SYPRO orange dye and chymostatin (10 
µM) were added to each buffer. The run conditions used were set to create a temperature 
range between 25°C and 99°C whereby the temperature was set to increase at 0.5°C 
increments after holding at a temperature for 5 seconds and thereafter recording the 
fluorescence. The data obtained from testing the compounds with different 
combinations of buffers were thereafter analysed by using the Rotor-GeneTM 6000 
series software version 1.7. 
 
2.2.7.  Determining the stability of TcoCATLcat via the thermal shift assay 
2.2.7.1.  Determining the effect of pH on the stability of TcoCATLcat 
Two separate buffer libraries were prepared to test the effect of pH on the stability of 
TcoCATLcat. The first buffer library was adapted from the buffer library by Reinhard 
et al (2012). The buffer library consisted of the following buffers each at 50 mM; 
sodium acetate, pH 4.5; sodium citrate, pH 4.0, pH 5.0 and pH 5.5; sodium phosphate, 
pH 6.0; PBS, pH 7.4; bicine, pH 8.0 and CHES, pH 9.5. The second buffer library 
prepared made use of a single AMT buffer adjusted to different pH-values. The buffer 
consisted of 100 mM acetate, 100 mM MES and 200 mM Tris and 4 mM EDTA. AMT 
buffers were prepared at pH 4.0, 4.5, 5.5, 6.0, 6.5, 7.0, 7.5 and 8. The effect of each 
buffer on the stability of TcoCATLcat was tested using the TSA. The volume of each 
buffer, the concentration of TcoCATLcat (0.1 µg/µl) and SYPRO orange dye (5X) was 
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kept constant. The conditions for each run were set as per the optimised conditions in 
section 2.2.5. The fluorescence was read by using the HRM channel on the RT-PCR 
with the gain optimisation option selected. The temperature profile tested was set from 
25°C to 99°C. The temperature was set to increase in 0.5°C increments with the holding 
time set to 5 seconds. The data obtained was thereafter analysed using the Rotor-
GeneTM 6000 series software version 1.7. 
 
2.2.7.2. Determining the effect of ligand binding on the stability of TcoCATLcat 
The compound library consisting of 50 compounds were extracted from the DIVERSet 
ChemBridge Library of compounds (ChemBridge Corp, USA). The structures of these 
compounds are found in appendix A. The 50 compounds were tested on TcoCATLcat 
along with chymostatin as it is an inhibitor of cysteine proteases. The compounds from 
the library were tested at a concentration of 10 µM at a constant pH of 7.4 (PBS) whilst 
chymostatin was tested at concentrations from 10 µM to 50 µM. The compounds were 
tested against 0.1 µg/µl of TcoCATLcat with 5X SYPRO orange dye. The run conditions 
were set to create a temperature range from 25°C to 99°C with the temperature set to 
increase in increments of 0.5°C after holding at each temperature point for 5 seconds. 
The data obtained from testing the compounds were thereafter analysed by using the 
Rotor-GeneTM 6000 series software version 1.7. 
 
2.2.7.3. Determining the combined effect of pH and ligand binding on the 
stability of TcoCATLcat 
The combination of applying a pH change and a ligand interaction with TcoCATLcat 
was then tested by using TcoCATLcat and the inhibitor chymostatin with a variety of 
different buffers. The buffers that were tested were sodium citrate at pH 4.0, pH 5.0, 
pH 5.5 and sodium phosphate pH 6.0. The buffers were tested with TcoCATLcat (0.1 
µg/µl) using 5X SYPRO orange dye and chymostatin (10 µM). The run conditions used 
were set to create a temperature range between 25°C and 99°C whereby the temperature 
was set to increase at 0.5°C increments after holding at a temperature for 5 seconds and 
thereafter recording the fluorescence. The data obtained from testing the compounds 
with different combinations of buffers were thereafter analysed by using the Rotor-





2.2.8. Statistical analysis 
The experiments were performed in triplicate with the averages and standard deviations 
calculated using Microsoft Excel from Microsoft Office (Microsoft Corporation, 
Version 18.1903.1152.0). The p-values of the data sets were determined by performing 
T-tests. The T-tests were calculated using the Simple Interactive Statistical Analysis 
(SISA) online tool (http://www.quantitativeskills.com/sisa/statistics/t-test.htm) using a 




3.1.  Hydrophobicity analysis of papain 
The amino acid sequence and composition of papain is displayed in Figure 3.1 with the 
amino acids which contribute to the protein’s overall hydrophobicity highlighted in 
different colours. The amino acids highlighted in Figure 3.1 were then scored based on 
the Kyte and Doolittle index as per Table 3.1. Specifically, the amino acids which 
contribute to a protein’s hydrophobicity according to the Kyte and Doolittle index were 
alanine, cysteine, isoleucine, leucine, methionine, phenylalanine and valine. 
             MAMIPSISKLLFVAICLFVYMGLSFGDFSIVGYSQNDLTSTERLIQLFESWMLKHNKIYK  60 
      NIDEKIYRFEIFKDNLKYIDETNKKNNSYWLGLNVFADMNDEFKEKYTGSIAGNYTTTEL  120 
 SYEEVLNDGDVNIPEYVDWRQKGAVTPVKNQGSCGSCWAFSAVVTIEGIIKIRTGNLNEY  180 
 SEQELLDCDRRSYGCNGGYPWSALQLVAQYGIHYRNTYPYEGVQRYCRSREKGPYAAKTD  240 
 GVRQVQPYNEGALLYSIANQPVSVVLEAAGKDFQLYRGGIFVGPCGNKVDHAVAAVGYGP  300 
 NYILIKNSWGTGWGENGYIRIKRGTGNSYGVCGLYTSSFYPVKN                  345 
Figure 3.1: The amino acid sequence for papain with hydrophobic residues highlighted. 
The following amino acids were identified from the papain sequence as contributing to the 
hydrophobicity of the protein: alanine (green), cysteine (cyan), isoleucine (purple), leucine 
(red), methionine (yellow), phenylalanine (dark aqua) and valine (blue).  
 
Table 3.1: The total number of each hydrophobic amino acid present in the papain 














Alanine (Ala) A 18 1.8 
Cysteine (Cys) C 8 2.5 
Isoleucine (Ile) I 23 4.5 
Leucine (Leu) L 24 3.8 
Methionine (Met) M 5 1.9 
Phenylalanine (Phe) F 13 2.8 
Valine (Val) V 24 4.2 
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Of the 345 amino acids comprising papain, 115 were scored as hydrophobic residues 
as per the Kyte and Doolittle scale (Table 3.1) with isoleucine and valine possessing 
the highest hydrophobicity scores of 4.5 and 4.2, respectively. As such, isoleucine 
accounted for 20% while valine accounted for 20.87% of the hydrophobicity observed 
in papain. Thereafter, papain was visualised through a Kyte and Doolittle 
hydrophobicity plot, a helical wheel form and a hydrophobicity cluster analysis (HCA) 
(Figure 3.2.)  
A Kyte and Doolittle hydrophobicity plot (Figure 3.2A) was used to evaluate and 
visualise the hydrophobicity of papain. The hydrophobicity plot revealed that 
hydrophilic residues dominated the protein sequence, indicative of a cytosolic protein. 
The hydrophobic residues present comprised the N-terminal and C-terminal and 
spanned periodically through the full-length sequence. A helical wheel analysis (Figure 
3.2B) and HCA (Figure 3.2C) further visualised regions of the protein which were rich 
in hydrophobic residues. The amino acids encircled in Figure 3.2.B represents the 
hydrophobic face of the helical wheel projection. The HCA grouped the hydrophobic 
amino acids within the sequence and it was observed that there are numerous 
hydrophobic clusters within the sequence of papain. The amino acid sequence of papain 
was then used to generate a theoretical melting point. The TM index calculated for 
papain was 1.46, which corresponded to a predicted melting temperature greater than 









Figure 3.2: Analysis of the hydrophobicity of papain. (A) Plot of hydrophobicity score for the amino acid sequence of papain using the Kyte and 
Doolittle index. The plot displays the assigned Kyte-Doolittle index score assigned to a specific amino acid plotted against the amino acid position. (B) 
Helical wheel analysis for papain with the hydrophobic face encircled. (C) Hydrophobicity cluster analysis of papain where the hydrophobic residues 
are marked in green and are grouped together by a black outline. 
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3.2.  Hydrophobicity analysis of TcoCATLcat  
The amino acid composition for TcoCATLcat is displayed in Figure 3.3 with the amino 
acids which contribute to the hydrophobicity score highlighted. These highlighted 
amino acids were scored based on the Kyte and Doolittle index listed in Table 3.2. The 
hydrophobicity of TcoCATLcat was further evaluated and visualised using three 
different methods, i.e. Kyte and Doolittle hydrophobicity plot, helical wheel analysis 
and hydrophobicity cluster analysis (Figure 3.4). 
APEAVDWRKKGAVTPVKDQGQCGSCWAFSAIGNIEGQWKVAGHELTSLSEQMLVSCDTND      60 
FGCEGGLMDDAFKWIVSSNKGNVFTEQSYPYASGGGNVPTCDKSGKVVGAKIRDHVDLPE        120 
DENAIAEWLAKNGPVAIAVDATSFQSYTGGVLTSCISEHLDHGVLLVGYDDTSKPPYWII        180 
KNSWSKGWGEEGYSALRRHN QCLMKNLPSSAVVSG                              215 
Figure 3.3: The amino acid sequence for TcoCATLcat with hydrophobic residues 
highlighted. The following amino acids were identified from the TcoCATLcat sequence as 
contributing to the hydrophobicity of the protein: alanine (green), cysteine (cyan), isoleucine 
(purple), leucine (red), methionine (yellow), phenylalanine (dark aqua) and valine (blue).  
 
Table 3.2: The total number of each hydrophobic amino acid present in the 

















Alanine (Ala) A 17 1.8 
Cysteine (Cys) C 7 2.5 
Isoleucine (Ile) I 9 4.5 
Leucine (Leu) L 13 3.8 
Methionine (Met) M 3 1.9 
Phenylalanine (Phe) F 5 2.8 
Valine (Val) V 18 4.2 
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The hydrophobicity for TcoCATLcat, based on the Kyte and Doolittle index, revealed 
that the amino acid sequence had a higher degree of hydrophilicity (Figure 3.4A) as the 
sequence contains 72 hydrophobic amino acids (33.38% of the amino acid residues for 
TcoCATLcat). The helical wheel plot and the HCA (Figure 3.4B and C) revealed several 
regions of hydrophobicity within the sequence and a distinct hydrophobic face. The TM 
index of TcoCATLcat was predicted to be 1.11 and the melting temperature was 
calculated to be higher than 65°C. 
3.3. The expression of recombinant TcoCATLcat  
The pPIC 9 yeast (Pichia pastoris) expression vector with the TcoCATLcat insert, 
previously been transformed into GS115 yeast cells was used to express the 
recombinant TcoCATLcat. Three-phase partitioning was used to isolate the expressed 
protein from the medium as per standard protocol (Dennison and Lovrien, 1997). The 
concentration of the expressed TcoCATLcat was determined via the Bradford assay and 
an average concentration of 5 µg/µl / expression was recorded. The expressed 
TcoCATLcat was separated on a 12% polyacrylamide gel (Figure 3.5). 
 
 
Figure 3.5: SDS-PAGE analysis for the expressed TcoCATLcat on 12% TGX FastCast 
acrylamide gels. (A) Non-reducing SDS-PAGE gel loaded with Precision Plus protein standard 
in lane 1, 1.5 µg TcoCATLcat loaded in lane 2 and 2 µg TcoCATLcat loaded in lane 3. (B) 
Reducing SDS-PAGE gel loaded Precision Plus protein standard in lane 1, 1.5 µg TcoCATLcat 
loaded in lane 2 and 2 µg TcoCATLcat loaded in lane 3. 
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Figure 3.4: Analysis of the hydrophobicity of TcoCATLcat. (A) Hydrophobicity score for the amino acid composition of TcoCATLcat using the Kyte 
and Doolittle index. The plot displays the assigned Kyte-Doolittle index score assigned to a specific amino acid plotted against the amino acid position. 
(B) Helical wheel analysis for TcoCATLcat where the hydrophobic face is encircled. (C) Hydrophobicity cluster analysis of TcoCATLcat where the 
hydrophobic residues are marked in green and are grouped together by a black outline
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When analysed on an SDS-PAGE gel under non-reducing conditions, the over-
expressed protein appeared as a single band with a molecular weight of 54 kDa (Figure 
3.5A) which correlated with the expected size of the TcoCATLcat dimer. The expressed 
protein appeared as a single band with a molecular weight of 27 kDa (Figure 3.5B) 
under reducing conditions, which agreed with the expected size of TcoCATLcat 
monomer (Authié et al, 1992). The protein sample appeared as a single band in both 
the non-reducing gel and the reducing gel which suggested that the expressed protein 
was free of contaminating proteins under the staining conditions employed. The 
expressed protein was further evaluated by means of a western blot. The protein sample 
was probed and detected by the affinity purified chicken-anti-TcoCATLcat IgY primary 
antibody specific to TcoCATLcat (previously isolated, Pillay et al, 2010) as evident by 
the single band detected on the PVDF membrane (Figure 3.6B) following exposure of 
the membrane in WesternBright ECL chemiluminescent HRP substrate. The band 
detected on PVDF membrane in Figure 3.6B and the band observed for the expressed 
protein in the reducing SDS-PAGE gels in Figures 3.5B and 3.6A were of an apparent 
similar molecular weight. The affinity purified chicken-anti- TcoCATLcat IgY primary 
antibody did not detect the papain sample loaded in lane 1 (Figure 3.6A and B). 
 
Figure 3.6: The analysis of the expressed recombinant TcoCATLcat via western blot. (A) 
Reducing SDS-PAGE of the recombinantly expressed TcoCATLcat. Lane MWM, SeeBlue 
Plus2 pre-stained protein standard; lane 1, 5 µg of papain and lane 2, 2 µg TcoCATLcat in PBS 
buffer (pH 7.4). (B) Western blot of the recombinantly expressed TcoCATLcat. Lane MWM, 
SeeBlue Plus2 pre-stained protein standard; lane 1, 5 µg of papain and lane 2, 2 µg TcoCATLcat 
in PBS buffer (pH 7.4). The images of both the SDS-PAGE gel and the western blot were 
spliced to remove non-relevant wells containing samples not relevant to this section of work.  
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The gelatinolytic activity of the expressed TcoCATLcat was determined after separating 
the expressed protein samples on a gelatin substrate containing gel (Figure 3.7). The 
gelatin-based zymogram can be observed in Figure 3.7B alongside the control SDS-
PAGE gel in Figure 3.7A and a control gelatin-based zymogram showing the activity 
of papain in Figure 3.7C. The image revealed gelatin degradation in the lane loaded 
with the expressed TcoCATLcat. A single band was observed for the sample in both the 
SDS-PAGE and the zymogram, however, it appeared at different molecular weights 
with the degradation band present in the zymogram (Figure 3.7B) at a higher molecular 
weight (32 kDa) than the band in the corresponding SDS-PAGE (27 kDa) (Figure 
3.7A). The banding pattern of the SeeBlue Plus2 pre-stained protein standard appeared 
to follow the same trend. The molecular weight marker bands migrated a shorter 






Figure 3.7: Qualitative determination of enzymatic activity of TcoCATLcat via non-
reducing SDS-PAGE and gelatin-containing SDS-PAGE analysis with papain enzymatic 
activity on a gelatin-containing SDS-PAGE. (A) A standard SDS-PAGE 12.5% acrylamide 
gel used as a control with SeeBlue Plus2 pre-stained protein standard loaded in the lane marked 
MWM and 2 µg of expressed TcoCATLcat in lane 1. (B) A gelatin containing substrate SDS-
PAGE gel with SeeBlue Plus2 pre-stained protein standard loaded in the lane marked MWM, 
non-reducing buffer loaded in lane 1 and 2 µg of recombinantly expressed TcoCATLcat in lane 
2. (C) A gelatin containing substrate SDS-PAGE gel with 2 µg of papain in lane 1. 
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3.4. Evaluation of the dimerisation of TcoCATLcat 
The recombinantly-expressed TcoCATLcat protein was exposed to three different pH 
values and three distinct temperature conditions prior to separation via SDS-PAGE 
(Figure 3.8). A single visible band was observed in lanes 2, 3, 5, 6, 8 and 9 which 
represents TcoCATLcat as a monomer with an apparent molecular weight of 27 kDa. A 
change in banding pattern for TcoCATLcat was observed in lanes 4, 7 and 10. These 
lanes represented the samples that were exposed to a temperature of 90°C for 90 
seconds. The monomer was still present in these lanes however a band with a greater 
molecular weight was observed in lanes 7 and 10 (pH 7.4 and pH 8.0) which was not 
observed under acid conditions (pH 4.5) in lane 4. Previously, Boulangé and co-workers 
demonstrated a unique characteristic of this protein under acidic conditions through the 
transition from a dimer presents at neutral pH to a monomer under acidic pH conditions 
(Boulangé et al, 2011). The protein bands that resolved at the apparent molecular 
weight of the TcoCATLcat dimer (Figure 3.8) were detected when probed with protein-
specific antibody in a western blot analysis (Figure 3.9). Additionally, the bands that 
resolved on the membrane at the higher molecular weight were distinct and not 










Figure 3.8: An SDS-PAGE displaying the dimerisation of TcoCATLcat due to pH. The 
SeeBlue Plus2 pre-stained protein standard was loaded in lane 1. TcoCATLcat in pH 4.5 was 
held for 90 seconds at 30°C in lane 2, 60°C in lane 3 and 90°C in lane 4 before being loaded. 
This was repeated at pH 7.4 in lanes 5-7 and at pH 8.0 in lanes 8-10. The concentration of 
TcoCATLcat was kept constant at 2 µg. 













Figure 3.9: The evaluation of observed dimer formation of TcoCATLcat under neutral pH 
conditions using western blot. The SeeBlue Plus2 pre-stained protein standard was loaded in 
lane 1. TcoCATLcat was kept at 90°C for 90 seconds in PBS pH 7.4. A total of 2 µg was loaded 
in lane 2 and 3 µg loaded in lane 3. 
 
3.5. Thermal shift assay  
3.5.1.  Thermal shift kit 
The thermal shift kit (ThermoFisher Scientific, USA) was used to validate the use of 
the thermal shift assay for the identification of factors that influence a protein’s stability. 
The model protein, provided with the kit, was used at a final concentration of 0.08 µg/µl 
while the ligand was tested at concentrations of 0.1 mM, 0.5 mM and 1.0 mM. A 
comparison of the raw fluorescence obtained for the model protein alone was compared 
to the raw fluorescence obtained when the model protein was combined with the 
thermal shift kit control ligand at different concentrations is shown in Figure 3.10. The 










Figure 3.10: Raw fluorescence obtained for the model protein in the absence and presence 
of the control ligand at various concentrations. The real time fluorescence detected for the 
model protein was plotted against temperature (°C). The fluorescence of the model protein with 
the ligand absent is displayed in red, followed by the model protein with the addition of 0.1 
mM ligand displayed in pink. Thereafter, the protein with the addition of 0.5 mM ligand is 
displayed in green and lastly the protein with the highest ligand concentration (1.0 mM) 
represented in blue. The Boltzmann TM for the protein with the ligand absent was calculated to 
be 44.15°C and the Boltzmann TM for the protein with the ligand added at a final concentration 
of 1mM was calculated to be 49.18°C, resulting in a TM shift of 5.03°C.   
 
The melting point of the model protein was determined by calculating the derivative 
(dF/dT) of the raw fluorescence obtained. The calculated derivative of the raw 
fluorescence obtained against temperature was plotted in Figure 3.11. By calculating 
the derivate (dF/dT), the Boltzmann TM was clearly visible and represented by the peaks 
shown in Figure 3.11 as compared to the Boltzmann TM (represented by the midpoint 
of the increase in fluorescence) obtained in Figure 3.10. The TM of the model protein 
increased as the concentration of the ligand increased. The 1 mM concentration of 
ligand effectively increased the TM of the protein from 44.15°C to 49.18°C (p < 0.5) 
and this was the greatest shift observed as compared to lower ligand concentrations. 
The derivative of the fluorescence obtained increased in intensity as the concentration 
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Figure 3.11: Differential scanning fluorimetry analysis obtained for the thermal shift 
control protein in the absence and presence of the control ligand at various 
concentrations. The calculated derivative of raw fluorescence (dF/dT) was plotted against 
temperature (°C). The derivative of the model protein displayed in red, followed by the model 
protein with the addition of 0.1 mM ligand displayed in pink, thereafter the protein with the 
addition of 0.5 mM ligand displayed in green and lastly the protein with the highest ligand 
concentration (1.0 mM) tested represented in blue. The melting point for the protein without 
the addition of the ligand was 44.15°C and the melting point of the protein with 1.0 mM ligand 
was 49.18°C, with a TM difference of 5.03°C. 
 
 
3.6.  Determining the stability of papain via the TSA 
3.6.1. Determining the effect of pH on the stability of papain 
The TSA was implemented to determine the stability of papain under various pH 
conditions by a measure of the melting point of the protein in combination with the 
Reinhard et al (2012) or AMT buffer libraries. Through this analysis, it was clearly 
observed that the melting temperature of papain was dependent on the buffer used 
(Table 3.3). Specifically, the melting temperature of papain increased as the pH 
decreased from pH 8 to 4.5 - at which point the highest melting point (83.40 ± 0.10°C) 
of the protein was obtained (Table 3.3). This would suggest that papain stability is 
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Table 3.3: The average melting temperature obtained for papain under various 
buffer conditions  
 
a Std Dev; standard deviation, n = 3 
b AMT, Acetate-MES-Tris 
 
Further decrease in the pH level, however, served to decrease the stability of papain. 
As shown in Table 3.3, the melting temperature decreased from 83.40°C at pH 4.5 to 
80.92°C at pH 4.0). These findings correlated with a previous report in which papain 
was determined to undergo acid denaturation and unfold at pH 2.0 (Fosado-Quiroz and 
Rojo-Dominguez, 2011). The unfolding of papain was further explained by Huet and 
co-workers as they described papain undergoing state changes when exposed to acidic 
pH’s (Huet et al, 2006). The authors concluded that papain appeared in its native state 
between pH 4-10 and transitioned to a molten globule state between pH 2-4 (Huet et al, 
2006). The molten globule state was less stable than the native state. Accordingly, this 
can account for a decrease in stability for papain when solvated within the sodium 
citrate pH 4.0 buffer.  
 
 
Reinhard buffer library Papain 
TM ± Std Deva (°C) 
Sodium citrate pH 4.0 80.92 ± 0.14 
Sodium citrate pH 5.0 82.83 ± 0.14 
Sodium citrate pH 5.5 82.13 ± 0.13 
Sodium phosphate pH 6.0 81.95 ± 0.09 
MES pH 6.7 80.33 ± 0.08 
PIPES pH 6.7 80.65 ± 0.09 
MOPS pH 7 80.52 ± 0.08 
Sodium phosphate pH 7 79.50 ± 0.43 
PBS pH 7.4 79.22 ± 0.06 
Bicine pH 8 78.83 ± 0.14 
HEPES pH 8 78.95 ± 0.09 
AMTb buffer library  
AMT pH 4.5  83.40 ± 0.10 
AMT pH 5.5 82.12 ± 0.13 
AMT pH 8.0 80.92 ± 0.14 
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A representative derivative plot of papain exposed to three different pH conditions 
revealed that there was a significant TM difference of 3.85°C (p < 0.05) between the TM 
obtained using PBS, pH 7.4, and that obtained when using sodium citrate, pH 5.0 
(Figure 3.12). A significant difference (p < 0.05) in melting point was also observed for 
papain in sodium citrate buffers of pH 4.0 and pH 5.0. It was also noted that the 
derivative of fluorescence against temperature obtained decreased as the melting point 
of papain increased. This decrease in fluorescence has been accounted for previously 
by the effect that the pH has on the binding of SYPRO orange to the hydrophobic 
regions of the protein (Ericsson et al, 2006; Reinhard et al, 2012; Huynh and Partch, 
2016). Additionally, this trend has been described by Bai et al (2019) and Cimmperman 
et al (2008) as a reduction in available hydrophobic regions for the SYPRO orange dye 
to bind due to an increase in the stability of the protein. The decrease in the intensities 
of fluorescence observed, however, does not influence the melting point of the protein 
(Ericsson et al, 2006; Reinhard et al, 2012).  
 
Figure 3.12: Differential scanning fluorimetry analysis obtained for papain under 
different pH conditions. The melting point for papain using three different buffers from the 

















Papain in sodium citrate pH 4 Papain in sodium citrate pH 5 Papain in PBS pH 7.4
TM = 79.22°C 
TM = 80.92°C 
TM = 82.83°C 
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3.6.2. Determining the effect of ligand binding on the stability of papain 
The compounds obtained from the ChemBridge library were analysed at a final 
concentration 10 µM and at pH 7.4 using PBS as the standard buffer. The average TM 
obtained for the library of compounds with their standard deviation are shown in Table 
3.4. The compound chymostatin, which was not part of the ChemBridge library, was 
used as a control. The compounds from the ChemBridge library were unable to shift 
the TM of papain by a margin greater than 1°C when used at a final concentration of 10 
µM. The observed shifts in TM of papain when in the presence of these compounds 
were negligible (p > 0.05). The lack of binding may be due to the structure of the 
compounds or inadequate concentration of ligands tested.  
Table 3.4: The average melting temperature obtained for papain in the presence 
of distinct compounds and within phosphate buffered saline (pH 7.4) by means of 











5118317 78.95 ± 0.09 
N, N'-(1-methyl-4,4-piperidinediyl) diacetamide 5118841 79.17 ± 0.08 
2-butyl-5-methylisophthalic acid 5119061 79.05 ± 0.18 
N-[1-(1-adamantyl) ethyl]-N'-propylurea 5142981 79.03 ± 0.06 
2-{[3-(trifluoromethyl)phenyl] amino} 
benzamide 
5144439 79.00 ± 0.00 
N-(tert-butyl)-2-hydroxy-3-(4-
methoxyphenoxy)-1-propanaminium chloride 
5144520 78.97 ± 0.06 
3-[(1,1-dioxidotetrahydro-3-thienyl) amino]-
1,2-propanediol 
5155819 78.92 ± 0.08 
3-(4-bromophenoxy) tetrahydrothiophene 1,1-
dioxide 
5155858 78.95 ± 0.18 
4-(4-morpholinylsulfonyl) benzoic acid 5156995 79.10 ± 0.09 
2-(3-chlorophenoxy) propanohydrazide 5189169 79.15 ± 0.00 
1,6-diethyltetrahydroimidazo[4,5-d] imidazole-
2,5(1H,3H)-dione 





5411732 79.10 ± 0.00 
1-(3-chlorophenyl)-4-(2,5- difluorobenzyl) 
piperazine 
5414621 78.97 ± 0.06 
N-(2,6-difluorobenzyl)-N', N'-diethyl-N-
methyl-1,2-ethanediamine 
5415800 78.97 ± 0.06 
1-(3-methylcyclopentyl)-4-(3-phenylprop-2-en-
1-yl) piperazine dihydrochloride 
5417271 79.00 ± 0.00 
methyl 4-{[4-(2,3-dimethylphenyl)-1-
piperazinyl] methyl} benzoate 
5418608 79.18 ± 0.06 
1-(2,5-difluorobenzyl)-4-methylpiperazine 5419034 79.08 ± 0.18 
1-ethyl-4-(3-phenylbutyl) piperazine 5430819 79.03 ± 0.06 
N-ethyl-N', N'-dimethyl-N-[2-(trifluoromethyl) 
benzyl]-1,2-ethanediamine 
5430906 79.12 ± 0.13 
4-(2-fluorobenzyl) morpholine 5431331 79.08 ± 0.08 
N-[3-(dimethylamino) propyl]-N', N'-dimethyl-
N-(2-naphthylmethyl)-1,3-propanediamine 
5431334 79.00 ± 0.10 
2-[(2,4-difluorobenzyl) (propyl)amino] ethanol 5431798 79.07 ± 0.06 
1-[(2-methoxy-1-naphthyl) methyl]-4-
methylpiperazine 
5431935 78.95 ± 0.09 
6-bromo-5-methyl-3H-imidazo[4,5-b] pyridine 5722012 79.00 ± 0.00 
4-benzoyl-3-hydroxy-1-methyl-5-phenyl-1,5-
dihydro-2H-pyrrol-2-one 




5791634 78.88 ± 0.13 
2-(benzylthio)-6,7-dihydro-5H-cyclopenta [4,5] 
thieno[2,3-d] pyrimidin-4-amine 
6136720 79.03 ± 0.06 
2-(4-methoxyphenyl)-3-[(2-phenylethyl) 
amino]-1H-inden-1-one 
6194607 79.12 ± 0.13 
1-allyl-4-benzoyl-3-hydroxy-5-phenyl-1,5-
dihydro-2H-pyrrol-2-one 





6271753 79.00 ± 0.15 
5-chloro-N-ethyl-2-methoxy-N-
phenylbenzamide 
6612023 79.03 ± 0.06 
4-chloro-1-(2-ethoxybenzoyl)-1H-pyrazole 6660132 79.08 ± 0.14 
10-(1-methylethylidene)-4-phenyl-4-
azatricyclo [5.2.1.0~2,6~] dec-8-ene-3,5-dione 
6714292c 79.17 ± 0.14 
1-(2-chloro-4-nitrobenzoyl)-4-ethylpiperazine 6800944 79.00 ± 0.00 
5-chloro-2-[(2-fluorobenzyl) oxy] benzaldehyde 
oxime 
6832681 79.00 ± 0.00 
5-chloro-2-[(3-fluorobenzyl) oxy] benzaldehyde 
oxime 
6843219 78.87 ± 0.03 
1-[cyclohexyl(methyl)amino]-3-(4-
methoxyphenoxy)-2-propanol hydrochloride 
6943696d 78.87 ± 0.13 
4-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]-N, N-
dimethyl-1-piperazinecarboxamide 
6950620 78.3 ± 1.13 
1-(4-chlorophenyl)-4-(tetrahydro-2-
furanylcarbonyl) piperazine 
7275637 79.12 ± 0.13 
3-cyclopentyl-N-(4-pyridinylmethyl) 
propanamide 




7294926 78.93 ± 0.06 
1-(2-ethylhexanoyl)-3,5-dimethyl-1H-pyrazole 7299305 78.98 ± 0.13 
3-(4-chlorophenyl)-N-(2-methoxy-1-
methylethyl) acrylamide 
7364709 78.95 ± 0.13 
2-{4-[3-(methylamino)-4-nitrophenyl]-1-
piperazinyl} ethanol 
7951028 79.08 ± 0.08 
2-(cyclopentylamino)-N-(4-methoxy-2,5-
dimethylphenyl)-2-thioxoacetamide 
7952968 78.90 ± 0.09 
N-({[2-chloro-5-(trifluoromethyl) phenyl] 
amino} carbonyl)-2,2,2-trifluoroacetamide 






7953379 79.03 ± 0.06 
6-(1,3-benzodioxol-5-yl)-1,3,5-triazinane-2,4-
dithione 
7953623 78.88 ± 0.13 
4-bromo-1-(2,6-dichlorobenzyl)-1H-pyrazole 7955822 79.03 ± 0.06 
4,5-dimethyl-2-(4-nitrophenyl)-1H-imidazol-1-
ol 3-oxide 
7959564 79.03 ± 0.20 
50 uM Chymostatin  84.38 ± 0.23 
60 uM Chymostatin  83.48 ± 0.20 
a Ligands tested at 10 µM 
b Std Dev; Standard deviation, where n = 3. 
c-d Compounds used for representative dF/dT vs temperature (°C) plot 
 
Compound 6714292 and compound 6943696 listed Table 3.4 were used to generate the 
representative plot (Figure 3.13). The control for the experiment was papain dissolved 
in PBS pH 7.4 in the absence of a compound which returned a TM of 79.25°C. The TM 
remained unchanged when compound 6714292 and compound 6943696 (p > 0.05) were 
introduced. Furthermore, these two compounds did not affect the intensities of the 
fluorescence obtained. The TSA obtained for papain in the presence of increasing 
concentrations of chymostatin was used to generate the derivative plot (Figure 3.14). 
The melting point of the protein increased significantly (p < 0.05) from 79.25°C to a 
maximum of 84.35°C as the concentration of chymostatin increased from 10 µM to 50 
µM (Table 3.4). The addition of 60 µM chymotrypsin served to decrease the melting 




Figure 3.13: A representative differential scanning fluorimetry analysis obtained for 
papain with compounds from the ChemBridge library. The dF/dT vs temperature was 
plotted for papain in the absence of a ligand and in the presence of ligands 6714292 and 
6943696 at 10 µM. The TM of the samples are represented by the peaks in the graph. 
 
Figure 3.14: Differential scanning fluorimetry analysis of papain with increasing 
concentrations of chymostatin. The dF/dT vs temperature for papain in the absence and the 

















Papain with compound 6714292 Papain with compound 6943696


















Papain Papain with 10 µM chymostatin
Papain with 30 µM chymostatin Papain with 50 µM chymostatin
Papain with 60 µM chymostatin
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3.6.3. Determining the combined effect of pH and ligand binding on the stability 
of papain. 
A combination of the buffer library and the control ligand, chymostatin, was used to 
evaluate if the melting temperature of papain could be increased further. The average 
TM for each of the combinations tested is shown in Table 3.5. The derivative plot for 
these combinations and the observed TM for a representative run are shown in Figure 
3.15. The TM of papain was shown to increase with a decrease in the pH of the buffers 
in which the protein was dissolved. The TM for papain is increased further by the 
addition of 50 µM chymostatin for each of the buffers except for sodium citrate pH 4.0. 
In this solitary instance in which a decrease in melting temperature was observed in the 
presence of chymostatin, the TM decreased significantly from 80.68°C to 78.78°C (p < 
0.05). This decrease is supported by the state change explained by Huet et al (2006) 
and may be due to the inability of chymostatin to bind to the globular state of papain. 
The largest increase in TM due to the addition of chymostatin was observed for papain 
in sodium citrate pH 5.5 in which the TM increased from 82.22 ± 0.06°C to 84.35 ± 
0.09°C - a statistically significant increase of 2.13°C (p < 0.05). Taken together, the 
highest melting point obtained for papain was 84.45 ± 0.26°C, which was obtained 
through the combination of chymostatin and a pH of 5.0 (Table 3.5).  
Table 3.5: The average TM obtained for papain when testing combinations of pH 
and 50 µM chymostatin 
 
a Std Dev; Standard deviation, where n = 3. 
 
Buffer and compound Papain  
TM ± Std Deva (°C) 
Sodium citrate pH 4.0 80.68 ± 0.12 
Sodium citrate pH 4.0 + 50 µM chymostatin 78.78 ± 0.12 
Sodium citrate pH 5.0 82.68 ± 0.12 
Sodium citrate pH 5.0 + 50 µM chymostatin 84.45 ± 0.26 
Sodium citrate pH 5.5 82.22 ± 0.06 
Sodium citrate pH 5.5 + 50 µM chymostatin 84.35 ± 0.09 
Sodium phosphate pH 6.0 81.71 ± 0.15 




Figure 3.15: Differential scanning fluorimetry analysis obtained demonstrating the 
effectiveness of a buffer-ligand combination on the stability of papain. The dF/dT vs 
temperature observed for papain under different combinations of buffer and ligand. The papain 
samples dissolved in different buffers in the absence of chymostatin are represented by solid 
lines and samples with the same pH conditions with the addition of 50 µM chymostatin are 
represented by dashed lines. 
 
3.7. Determining the stability of TcoCATLcat via the thermal shift assay 
3.7.1. Determining the effect of pH on the stability of TcoCATLcat 
The buffer libraries prepared were tested at constant volume with a constant 
concentration of TcoCATLcat (0.1 µg / µl) and SYPRO orange dye (5X). The respective 
average melting temperatures obtained for TcoCATLcat in each buffer was recorded 
(Table 3.6). It can be observed that the TM for TcoCATLcat reached its highest point 
when exposed to an acidic pH and gradually decreases as the pH is increased. This trend 
was observed in both the AMT buffer library (Figure 3.16) and the Reinhard et al 
















Papain in sodium citrate pH 4.0
Papain in sodium citrate pH 5.0
Papain in sodium citrate pH 5.5
Papain in sodium phosphate pH 6.0
Papain in sodium citrate pH 4.0 with 50 µM chymostatin
Papain in sodium citrate pH 5.0 with 50 µM chymostatin
Papain in sodium citrate pH 5.5 with 50 µM chymostatin
Papain in sodium phosphate pH 6.0 with 50 µM chymostatin
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 Table 3.6: The average melting temperature obtained for TcoCATLcat under 
various buffer conditions.  
 
 
a TcoCATLcat, catalytic domain of congopain 
b Std Dev; standard deviation, n = 3 
c AMT, Acetate-MES-Tris 
 
Figure 3.16: A representative differential scanning fluorimetry analysis obtained for the 
melting point of the catalytic domain of congopain (TcoCATLcat) in different Acetate-
MES-Tris (AMT) buffers. The dF/dT vs temperature observed for TcoCATLcat under various 
pH conditions using the AMT buffer library. The pH range displayed was between 5.0 and 8.0 
whilst keeping the concentration of protein and dye constant (0.1 µg/µl TcoCATL with 5X 
SYPRO Orange dye). 
Reinhard buffer library TcoCATLcata 
TM ± Std Devb (°C) 
Sodium citrate pH 4.0 65.27 ± 0.13 
Sodium acetate pH 4.5 64.57 ± 0.20 
Sodium citrate pH 5.0 63.45 ± 0.18 
Sodium citrate pH 5.5 60.32 ± 0.12 
Sodium phosphate PH 6.0 58.17 ± 0.08 
Phosphate buffered saline pH 7.4 47.12 ± 0.16 
Bicine pH 8 45.75 ± 0.10 
CHES pH 9.5 37.17 ± 0.29 
AMTc buffer library   
AMT pH 4.0 65.58 ± 0.29 
AMT pH 4.5 65.80 ± 0.18 
AMT pH 5.0 65.62 ± 0.20 
AMT pH 5.5 64.03 ± 0.20 
AMT pH 6.0 59.45 ± 0.43 
AMT pH 6.5 57.12 ± 0.13 
AMT pH 7.0 53.90 ± 0.09 
AMT pH 7.5 49.87 ± 0.13 













TcoCATLcat in AMT buffer pH 5.0 TcoCATLcat in AMT buffer pH 5.5
TcoCATLcat in AMT buffer pH 6.5 TcoCATLcat in AMT buffer pH 7.5
TcoCATLcat in AMT buffer pH 8.0
TM = 45.75°C 
TM = 49.87°C 
TM = 57.12°C 
TM = 64.03°C 
TM = 65.62°C 
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In the AMT buffers, TcoCATLcat yielded a minimum TM of 45.75°C when solvated 
within AMT buffer pH 8.0 and a maximum TM of 65.80°C when tested with the AMT 
buffer pH 4.5 (Table 3.6). The difference in TM between the maximum and minimum 
TM obtained in this buffer library was 20.05°C (p < 0.05). The highest TM for 
TcoCATLcat in the Reinhart library was observed when sodium citrate pH 4.0 and 
sodium acetate pH 4.5 were used. The melting temperatures recorded were 65.15°C and 
64.75°C, respectively. The lowest melting temperature for TcoCATLcat was observed 
when using the CHES pH 9.5 buffer which yielded a TM at 37.17°C. The TM difference 
between the maximum and minimum observed was calculated to be 28.15°C (p < 0.05). 
The catalytic domain of TcoCATL was previously described by Boulangé et al (2001) 
to be stable and demonstrate enzyme activity over an extensive range of pH with acidic 
pH conditions favoured. This correlates with the results shown in Figures 3.16 and 3.17 
which demonstrated that the stability of the protein is favoured in acidic conditions.  
 
Figure 3.17: A representative differential scanning fluorimetry analysis obtained for the 
melting point of the catalytic domain of congopain (TcoCATLcat) at different pH using the 
Reinhard buffer library. The dF/dT vs Temperature obtained for TcoCATLcat (0.1 µg / µl) 


















TcoCATLcat in sodium citrate pH 4.0 TcoCATLcat in sodium acetate pH 4.5
TcoCATLcat in PBS pH 7.4 TcoCATLcat in CHES pH 9.5
TM = 45.75°C 
TM = 47.12°C 
TM = 65.27°C 
TM = 64.57°C 
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3.7.2. Determining the effect of ligand binding on the stability of TcoCATLcat 
The ChemBridge library of compounds was used to determine the effect of ligand 
binding on the TM of TcoCATLcat at pH 7.4 and the average TM obtained for each of 
these compounds are shown in Table 3.7. The compounds from the ChemBridge 
Library were tested at 10 µM while chymostatin was tested at 50 µM. 
Table 3.7: The average melting temperature obtained for TcoCATLcat in the 
presence of distinct compounds and within phosphate buffered saline (pH 7.4) as 











5118317 47.30 ± 0.83 
N, N'-(1-methyl-4,4-piperidinediyl) 
diacetamide 
5118841 47.42 ± 0.64 




47.75 ± 0.80 
2-{[3-(trifluoromethyl) phenyl] amino} 
benzamide 




5144520 47.27 ± 0.78 
3-[(1,1-dioxidotetrahydro-3-thienyl) 
amino]-1,2-propanediol 
5155819 47.33 ± 0.80 
3-(4-bromophenoxy) tetrahydrothiophene 
1,1-dioxide 
5155858 47.22 ± 0.85 
4-(4-morpholinylsulfonyl) benzoic acid 5156995 47.30 ± 0.84 
2-(3-chlorophenoxy) propanohydrazide 5189169 47.25 ± 0.69 
1,6-diethyltetrahydroimidazo[4,5-d] 
imidazole-2,5(1H,3H)-dione 
5233951 47.23 ± 0.66 
1-(2-bromo-4,5-dimethoxybenzyl)-4-
phenylpiperazine 





5414621 46.95 ± 0.69 
N-(2,6-difluorobenzyl)-N', N'-diethyl-N-
methyl-1,2-ethanediamine 
5415800 47.15 ± 0.43 
1-(3-methylcyclopentyl)-4-(3-phenylprop-
2-en-1-yl) piperazine dihydrochloride 
5417271 47.05 ± 0.88 
methyl 4-{[4-(2,3-dimethylphenyl)-1-
piperazinyl] methyl} benzoate 
5418608 46.93 ± 0.72 
1-(2,5-difluorobenzyl)-4-methylpiperazine 5419034 46.88 ± 0.40 




5430906 47.17 ± 0.72 




5431334 47.08 ± 0.69 
2-[(2,4-difluorobenzyl) (propyl)amino] 
ethanol 
5431798 46.85 ± 0.69 
1-[(2-methoxy-1-naphthyl) methyl]-4-
methylpiperazine 
5431935 46.87 ± 0.34 
6-bromo-5-methyl-3H-imidazo[4,5-b] 
pyridine 
5722012 46.82 ± 0.72 
4-benzoyl-3-hydroxy-1-methyl-5-phenyl-
1,5-dihydro-2H-pyrrol-2-one 




5791634 47.17 ± 0.72 
2-(benzylthio)-6,7-dihydro-5H-cyclopenta 
[4,5] thieno[2,3-d] pyrimidin-4-amine 
6136720 46.95 ± 0.93 
2-(4-methoxyphenyl)-3-[(2-phenylethyl) 
amino]-1H-inden-1-one 





6197483 47.17 ± 0.62 
2-(2-chloro-4-fluorobenzyl)-5-(2-
methylphenyl)-2H-tetrazole 
6271753 46.88 ± 0.32 
5-chloro-N-ethyl-2-methoxy-N-
phenylbenzamide 
6612023 46.83 ± 0.33 




6714292 46.92 ± 0.21 
1-(2-chloro-4-nitrobenzoyl)-4-
ethylpiperazine 
6800944 47.08 ± 0.38 
5-chloro-2-[(2-fluorobenzyl) oxy] 
benzaldehyde oxime 
6832681 46.97 ± 0.38 
5-chloro-2-[(3-fluorobenzyl) oxy] 
benzaldehyde oxime 




6943696 46.85 ± 0.35 
4-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]-N, 
N-dimethyl-1-piperazinecarboxamide 
6950620 46.70 ± 0.13 
1-(4-chlorophenyl)-4-(tetrahydro-2-
furanylcarbonyl) piperazine 
7275637d 47.37 ± 0.65 
3-cyclopentyl-N-(4-pyridinylmethyl) 
propanamide 




7294926 47.30 ± 1.04 
1-(2-ethylhexanoyl)-3,5-dimethyl-1H-
pyrazole 
7299305 47.13 ± 0.78 
3-(4-chlorophenyl)-N-(2-methoxy-1-
methylethyl) acrylamide 




a Compounds tested at 10 µM 
b TcoCATLcat, catalytic domain of congopain 
c Std Dev; standard deviation, n = 3 
d-e Compounds used for representative dF/dT vs temperature (°C) plot 
The compounds from the ChemBridge library had little to no effect on the stability of 
TcoCATLcat as non-significant shifts (p > 0.05) in TM observed. The compounds which 
yielded the largest difference in TM for TcoCATLcat were used to construct a derivative 
plot represented in Figure 3.18. The TM observed for TcoCATLcat in the absence of a 
ligand was 47°C. An increase in TM was observed with the addition of compound 
7275637 as the TM increased to 47.15°C and the largest decrease in TM was observed 
with compound 7953623 as the TM decreased to 46.00°C. These negligible shifts 
suggest that the compounds tested are incapable of binding to the protein at 10 µM. In 
contrast, the addition of chymostatin influenced a significant increase (p < 0.05) in the 




7951028 46.80 ± 0.40 
2-(cyclopentylamino)-N-(4-methoxy-2,5-
dimethylphenyl)-2-thioxoacetamide 
7952968 46.68 ± 0.20 
N-({[2-chloro-5-(trifluoromethyl) phenyl] 
amino} carbonyl)-2,2,2-trifluoroacetamide 





7953379 46.67 ± 0.21 
6-(1,3-benzodioxol-5-yl)-1,3,5-triazinane-
2,4-dithione 
7953623e 46.25 ± 0.25 
4-bromo-1-(2,6-dichlorobenzyl)-1H-
pyrazole 
7955822 46.70 ± 0.49 
4,5-dimethyl-2-(4-nitrophenyl)-1H-
imidazol-1-ol 3-oxide 
7959564 46.83 ± 0.60 




Figure 3.18: A representative differential scanning fluorimetry analysis of congopain 
using compounds from the ChemBridge library and using chymostatin as a positive 
control. The dF/dT vs temperature for TcoCATLcat in absence and presence of two selected 
compounds from the ChemBridge library with chymostatin (50 µM) serving as a positive 
control and chymostatin in the absence of TcoCATLcat as a negative control when using 5X 
SYPRO orange dye. 
 
3.7.3. Determining the combined effect of pH and ligand binding on the stability 
of TcoCATLcat 
A combination of the buffer library and chymostatin was used to further stabilise 
TcoCATLcat. For each analysis, the buffer was kept at the same volume, the 
concentration of chymostatin was evaluated at 50 µM and the final concentration of 
TcoCATLcat was kept constant at 0.1 µg / µl. The average TM recorded for each of the 
pH-ligand combinations tested are shown in Table 3.8. The derivative plot for these 





















TcoCATLcat and compound 7275637 TcoCATLcat and compound 7953623
TcoCATLcat in PBS pH 7.4 TcoCATLcat and chymostatin
Chymostatin in PBS pH 7.4
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Table 3.8: The average TM obtained for TcoCATLcat in the presence of 50 µM 
chymostatin and varying pH.  
 
a TcoCATLcat, catalytic domain of congopain 
b Std Dev; standard deviation, n = 3 
 
Figure 3.19: Differential scanning fluorimetry analysis obtained for the combined effect 
of pH and ligand binding on the stability of the catalytic domain of congopain 
(TcoCATLcat). The dF/dT vs Temperature observed for TcoCATLcat under different 
combinations of buffer and ligand. The solid lines represent the TcoCATLcat samples which 
were made up of different buffers without the presence of chymostatin and the broken lines 
represent the same buffer with the addition of 50 µM chymostatin. 
Buffer and compound TcoCATLcata 
TM ± Std Devb (°C) 
Sodium citrate pH 4.0 65.32 ± 0.21 
Sodium citrate pH 4.0 + 50 µM chymostatin 64.72 ± 0.12 
Sodium citrate pH 5.0 63.48 ± 0.20 
Sodium citrate pH 5.0 + 50 µM chymostatin 64.53 ± 0.10 
Sodium citrate pH 5.5 60.52 ± 0.25 
Sodium citrate pH 5.5 + 50 µM chymostatin 63.05 ± 0.09 
Sodium phosphate pH 6.0 58.18 ± 0.06 



















TcoCATLcat in sodium citrate pH 4.0
TcoCATLcat in sodium citrate pH 5.5
TcoCATLcat in sodium phosphate pH 6.0
TcoCATLcat in sodium citrate pH 4.0 with 50 µM chymostatin
TcoCATLcat in sodium citrate pH 5.5 with 50 µM chymostatin
TcoCATLcat in sodium phosphate pH 6.0 with 50 µM chymostatin
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The combination of using the buffer library with chymostatin on TcoCATLcat resulted 
in further stabilisation of the protein. The TM for TcoCATLcat was increased further by 
the addition of 50 µM chymostatin for each of the buffers except for sodium citrate pH 
4.0 as the TM decreased from 65.32°C to 64.72°C. This decrease was, however, 
negligible (p > 0.05). The lack of a shift was likely due to the inability of chymostatin 
to bind to the protein at that pH. The greatest increase in TM due to the combination of 
pH and ligand was observed for sodium citrate pH 6.0 as the TM increased by 3.17°C 





Proteases are of significant scientific importance and are subject to extensive 
investigation for research purposes and industrial applications (Mótyán et al, 2013). 
Cysteine proteases are ubiquitous enzymes with multifaceted roles in a range of 
biological organisms and have been previously exploited for industrial purposes 
(Mótyán et al, 2013). This study was designed with the aim of determining the precise 
experimental conditions that would favour the stabilisation of two cysteine proteases; 
namely papain and TcoCATLcat (commonly known as congopain). For this study, 
papain was selected as it is the founder enzyme of the large C1 family of papain-like 
cysteine proteases and widely used as a model representative of cysteine proteases 
(Kimmel and Smith, 1954). A wealth of knowledge exists for this enzyme as it has been 
extensively studied and successfully crystallised (Kamphuis et al, 1984). The second 
cysteine protease selected for this study was TcoCATLcat. As the major cysteine 
protease of Trypanosoma congolense, TcoCATLcat is considered a potential drug target 
and diagnostic. While much is known about this enzyme, TcoCATLcat is yet to be 
successfully crystallised and the 3-D structure is yet to be resolved.  
Protein crystallisation typically involves large-scale screening of the protein in buffers 
of different composition and subsequent observation of crystal formation (Uson and 
Sheldrick, 1999; Wlodawer et al, 2007). A more recent, empirical approach to protein 
crystallisation involves the optimisation of solution parameters prior to attempted 
crystallisation, such as the determination of buffers and buffer components that serve 
to enhance protein stability (Wlodawer et al, 2007). A useful technique for determining 
protein stability, and one which is amenable to high throughput screening, is differential 
scanning fluorimetry (Pantoliano et al, 2001; Niesen et al, 2007). This technique is 
effectively applied in the thermal shift assay, in which the melting temperature or TM 
of a protein in monomeric form can be precisely determined following addition of a 
hydrophobic-binding fluorescent dye and detection via RT-PCR (Pantoliano et al, 
2001; Niesen et al, 2007). As melting point is inherently dependent on the stability of 
the protein, conditions that increase stability can be determined through the 
identification of conditions that significantly increase the TM (Pantoliano et al, 2001; 
Ericsson et al, 2006; Niesen et al, 2007). Similarly, this assay can be employed to 
determine stoichiometry of proteins as the separation of a protein dimer will produce a 
fluorescent peak at a lower melting temperature than the unfolding of the monomers. 
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Additionally, the thermal shift assay has been effectively utilised to identify small 
molecule protein binders as ligand binding similarly serves to increase the TM of the 
target protein (Vedadi et al, 2006).  
Accordingly, the thermal shift assay was considered the ideal method to determine the 
optimal conditions required to stabilise papain and TcoCATLcat. In order to achieve this 
aim, a number of objectives were addressed. Specifically, it was imperative to 
determine whether the two cysteine proteases were viable candidates for the thermal 
shift assay and then to obtain protein in sufficient concentration and purity to execute 
the planned experiments. Additionally, it was necessary to confirm the proteins’ 
identity and activity to ensure that a correctly-folded form of the protein was used in 
the thermal shift assay. Thereafter, two distinct buffer libraries and a small compound 
library were prepared and evaluated for their effect on the melting temperature of two 
cysteine proteases. Finally, it was sought to determine whether the melting temperature 
of a buffer-stabilised protein could be further stabilised through the addition of a 
weakly-binding small protease inhibitor, chymostatin.  
As discussed below in more detail, each of these objectives were successfully fulfilled, 
culminating in the identification of buffer conditions that optimally stabilised both 
proteins and the conclusion that chymostatin serves to stabilise both proteins. The 
thermal shift assay also neatly demonstrated the presence of TcoCATLcat in distinct 
dimer and monomer forms and clearly illustrated that chymostatin binds to TcoCATLcat 
in monomeric form. Taken together, this study details the experimentally-determined 
optimal conditions for enhancing the stability of papain and TcoCATLcat. The findings 
can therefore be used to facilitate further biochemical research of these proteins and, in 
particular, guide crystallisation efforts of TcoCATLcat. The findings may also provide 
a broad guideline for optimising the stability of other members of the cysteine protease 
family.  
4.1. Papain and TcoCATLcat are suitable for use in the thermal shift assay 
A literature search indicated that neither papain nor TcoCATLcat have been subjected 
to thermal shift assays to determine the proteins’ thermal stability. Accordingly, the 
cysteine proteases selected for this study were analysed to determine their suitability 
for use within the thermal shift assay. In general, proteins that are suitable for thermal 
shift analysis require low surface hydrophobicity, a hydrophobic core and a melting 
66 
 
temperature within the range of the instrument used (i.e. >90°C in this case) (Pantoliano 
et al, 2001; Ericsson et al, 2006; Niesen et al, 2007). Accordingly, the hydrophobicity 
of both proteins were determined through amino acid analysis, hydrophobicity plots, 
helical wheels and hydrophobicity cluster analysis. This analysis revealed that, 
although papain and TcoCATLcat both contain approximately 33% hydrophobic 
residues, papain has higher overall hydrophobicity owing to a larger content of the 
amino acids which score highly according to the Kyte and Doolittle index (i.e. 
isoleucine, leucine and valine) (Kyte and Doolittle, 1982).  Additionally, papain has a 
larger hydrophobic face than TcoCATLcat and a greater number of hydrophobic 
clusters. Interestingly, the hydrophobicity cluster analysis revealed numerous common 
clusters supporting published homology models showing that the two cysteine 
proteases may have secondary structure similarities (Lalmanach et al, 2002). Papain 
was observed to have greater surface hydrophobicity than TcoCATLcat, however, both 
proteins displayed prominent hydrophobic cores which rendered them suitable for the 
thermal shift assay. Finally, theoretical analysis predicted that both proteins would 
produce TM values higher than 65°C. Taken together, the two cysteine proteases 
selected for this study were deemed viable candidates for analysis via the thermal shift 
assay.  
4.2. Biochemical characterisation of the cysteine proteases selected for thermal 
shift analysis 
Prior to undertaking the thermal shift assay, it was essential to ensure the proteins were 
purified to homogeneity and in active forms. Papain was purchased from a commercial 
source as a purified product and its molecular weight and activity were confirmed 
through SDS-PAGE and a gelatin-containing zymogram, respectively. Following 
recombinant expression, TcoCATLcat was purified and resolved into a 54 kDa dimer 
and 26 kDa monomer through non-reducing and reducing SDS-PAGE, respectively. 
The identity of the protein was confirmed through western blot and its proteolytic 
activity using a gelatin-containing zymogram. Notably, a single band was observed for 
the protein in both the SDS-PAGE and the zymogram, however, it appeared at a higher 
molecular weight in the zymogram. This distinction has been previously observed by 
Heussen and Dowdle (1980) who pioneered using substrate-containing polyacrylamide 
gel to show proteolytic activity of plasminogen activators. Similarly, Hummel and co-
workers observed that a metalloprotease from the basidiomycete fungus Schizophyllum 
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commune of 57 kDa appeared at a molecular weight of 70 kDa when separated on a 
gelatin containing SDS-PAGE (Hummel et al., 1996). The slower migration observed 
was attributed to an interaction between the protease evaluated and the substrate by 
Hummel et al (1996). This may account for the higher position of the band observed 
within the zymogram obtained in this study. 
4.3. The stability of the cysteine proteases under neutral pH conditions. 
The thermal stability of a protein has always been a key factor towards the evaluation 
of a protein as it is linked with the functional activity of a protein and the structural 
folding of a protein (Chen et al, 2008; Scheiblhofer et al, 2017). The melting 
temperature of a protein is a popular measure of a protein’s thermal stability. The 
melting temperature of a protein may be easily determined if there is an established 3-
D structure available for the required protein. There is currently no available 3-D 
structure available for TcoCATLcat and therefore a precise theoretical melting point 
could not be determined based on the proteins structure. 
There are over 10 million amino acid sequences deposited in the UniProtKB/TrEMBL 
protein databases with less than 1% of these entries having verified protein structures. 
This led to numerous attempts at determining the thermal stability of a protein from the 
verified amino acid sequence (Ku et al, 2009). A theoretical melting point range was 
determined for papain and TcoCATLcat based on the amino acid sequence of the protein. 
This determination of the melting point was derived from using the online TM index 
program created by Ku et al (2009) which assigns a score for each amino acid in the 
sequence. The scores are generated based on the identity, position of the amino acid in 
the sequence and the identity and position of the amino acid before and after in the 
sequence, under neutral pH conditions. This method for determining a theoretical TM is 
capable of identifying a TM range rather than identifying a precise melting point (Ku et 
al, 2009). The theoretical TM range for papain and TcoCATLcat were both predicted to 
be greater than 65°C and this TM is regarded as a high TM based on the program index. 
The range determined from the program was limited, however, as it can only take the 
amino acid composition into consideration and does not factor in different transitional 
states of a protein or any other factors that can affect the stability of a protein such as a 
change in pH or the introduction of a ligand (Ku et al, 2009). The program is able to 
detect changes in TM due to mutations. Stability achieved due to changes in the amino 
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acid composition may be observed, however, it will only be detected if these changes 
are sufficient to increase the TM from a TM index of <1 which correlates to a TM of 
<55°C to a TM index of >1 which correlates to a TM of >65°C.  
The TSA was implemented to derive the experimental TM of papain and TcoCATLcat 
under neutral pH conditions where the pH was kept at 7.4 by using PBS buffer. The 
Protein Thermal ShiftTM Starter Kit (ThermoFisher Scientific, USA) was first used to 
optimise the parameters of the TSA for use with the Rotor-GeneTM 6000 2-Plex RT-
PCR machine. The kit contained a control ligand capable of stabilising the control 
protein and it was observed that increasing the concentration of ligand resulted in an 
increase in TM and an increase in the fluorescence obtained. The concentration of the 
SYPRO orange dye and the protein of interest does not affect the TM obtained, but 
rather affects the intensity of the fluorescence obtained (Ericsson et al, 2006; Niesen et 
al, 2007; Lavinder et al, 2009).  
The initial experimental parameters were determined by following those outlined when 
using the commercial thermal shift kit. These parameters were then optimised for 
papain and TcoCATLcat. The experimental TM observed under neutral pH conditions 
for papain was 79.22 ± 0.06°C and the TM for TcoCATLcat was 47.12 ± 0.16°C. The 
experimental TM observed for papain correlates with the predicted TM range >65°C 
however this correlation was not observed for TcoCATLcat as the experimental TM 
obtained from the TSA revealed a TM <65°C. However, this is accounted for by the 
dimerisation of TcoCATLcat under physiological conditions (Boulangé et al, 2011). The 
online TM predictor is incapable of incorporating this structural change into its 
algorithm. The TM of TcoCATLcat obtained from the TSA at neutral pH possibly 
represents the dimer dissociating at a lower temperature rather than protein unfolding. 
Papain was not affected by this structural change as it appears as a monomer under 
neutral pH conditions and does not transition to a dimer through pH manipulation 
(Sorrentino et al, 1981; Boulangé et al, 2001). Rather, the dimerisation of papain can 
be effected by the introduction of cross linkage reagents such as dimethyl suberimidate 





4.4. The factors contributing towards the stabilisation of the two cysteine 
proteases 
The stability of the two cysteine proteases were evaluated under neutral pH conditions 
and it was observed that TcoCATcat had a lower melting point than papain. The effect 
of pH manipulation and ligand binding were evaluated to determine if the melting 
temperature, and therefore the stability, of the cysteine proteases could be increased 
further. 
4.4.1. Increasing stability of the cysteine proteases by decreasing pH 
The buffer library designed by Reinhard et al (2012) was used in initial thermal shift 
assay experiments to test the effect of pH on the stability of papain and TcoCATLcat. 
The library prepared consisted of the buffers A1 - B12 from Reinhard et al (2012) as 
this provided the required pH range. The thermal shift assays performed using the 
Reinhard buffer library revealed that both cysteine proteases favoured an acidic pH as 
both showed general trends of decreasing stability as the pH increased above 5.5. The 
Reinhard library consisted of buffers which differed in pH and ionic strength and it is 
known that the ionic strength of a buffer solution has an effect on the stability of a 
protein. Therefore any changes in stability observed using the Reinhard buffer library 
could not be accounted for solely by the pH as the ionic strength variation introduced a 
contributing factor. A second library was therefore constructed with buffers of constant 
ionic strength to delineate between the influence of pH and ionic strength on protein 
stability. Evaluation of the AMT buffer library (Ellis and Morrison, 1982) yielded 
similar findings as the evaluation of the Reinhard library, whereby the cysteine 
proteases were found to be preferentially stabilised in a slightly acidic pH.  
The effect of ionic strength on stability was clearly evident and impacted both cysteine 
proteases. This was observed, for instance, when comparing the TM of papain when 
evaluated at pH 8.0 using the two different libraries. There, a significant difference in 
TM of 2.09°C (p < 0.05) was observed between the result obtained in AMT (TM = 
80.92°C) and that obtained in Bicine (TM = 78.83°C). The difference in stability was 
accounted for by the higher ionic strength of the AMT buffer as compared to the Bicine 
buffer. This result correlates with findings by Yang et al (1994) and Dominy et al 
(2002) who tested the effect of ionic strength on protein stability. These authors 
observed that the overall net charge of the protein determined whether an increased 
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ionic strength favours protein stability or results in destabilisation of the protein (Yang 
and Honig, 1994; Dominy et al, 2002).  
The TM of papain was increased from 79.22°C under physiological conditions to 
83.40°C using the AMT buffer at pH 4.5 which represented an increase in TM of 4.18°C 
(p < 0.05). The increase in TM observed for TcoCATLcat was even greater as the TM 
increased from 47.12°C under physiological conditions to 65.80°C when using AMT 
buffer pH 4.5, which equates to a significant increase of 18.68°C (p < 0.05). This 
significant shift in TM possibly represents the transition of TcoCATLcat in the 
monomeric form under physiological pH conditions to a dimeric form under acidic 
conditions. The lower melting point is indicative of the dissociation of a dimer and not 
the unfolding of the protein.   
The TM observed for TcoCATLcat when tested under physiological conditions revealed 
a low TM with a high dF/dT which indicated a higher raw fluorescence. The higher TM 
and lower dF/dT (thus indicating a lower raw fluorescence obtained) was observed 
when using acidic pH conditions. This fluctuation in raw fluorescence was not initially 
anticipated as the concentration of the protein was kept constant. The conformational 
changes occurring with TcoCATLcat under different pH conditions was not considered 
as a factor which contributed towards the decreased fluorescence as the same trend in 
fluorescence intensity was observed for papain for which there is no known 
conformational change due to pH changes. The trends observed in the raw fluorescence 
of both cysteine proteases indicated that the decrease in raw fluorescence of the proteins 
under acid pH conditions is not related to conformational changes of the protein 
occurring but may be due to the poor binding affinity of the SYPRO orange dye under 
acidic conditions. Alternatively, the proteins may be stabilised to a point and in such a 
manner that significantly fewer hydrophobic regions are exposed.  
4.4.2. Stabilisation of the selected proteases via the introduction of a ligand 
The thermal shift assay was used to detect changes in stability of the cysteine proteases 
when a ligand was introduced. For this study, E-64, the cysteine protease class-specific 
inhibitor, was considered for use in detecting a shift in the stability of the two cysteine 
proteases due to ligand binding as it is a strong inhibitor of cysteine proteases. Since E-
64 was first isolated from a culture of Aspergillus japonicus, it has been used as a 
common and potent inhibitor for numerous cysteine proteases including those of the 
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papain family (Matsumoto et al, 1999). The inhibitor is classified as a covalent-type 
irreversible inhibitor and commonly binds to the Sn (n= 1~3) subsites of cysteine 
proteases of the papain family due to the preserved tertiary structure of the C α-
backbone chains (Matsumoto et al, 1999). The N-terminal carboxyl group of E-64 
forms three hydrogen bonds with the catalytic Gln-19, Cys-25, and His-159 of the 
cysteine protease. The O5, N10 and N6 atoms of E-64 participate in electrostatic short 
contacts with Gly-66 amide NH, Gly-66 amide O and Asp-158 amide O, respectively. 
These interactions contribute to the stabilisation of the E-64-papain complex and is also 
responsible for the orientation of the inhibitor into a direction suitable for the 
nucleophilic attack by the active cysteine. In the E-64-papain complex, the S2 subsite 
consists of three residues (Val-133, Val-157, and Ala-160). The leucyl side chains of 
E-64 are located near the entry of the S2 hydrophobic pocket and is in van der Waals 
contact with the side chain of Val-133 and also with Ala-160 (Kim et al, 1992; 
Matsumoto et al, 1999).  
The described interaction of E-64 with papain and papain-like cysteine proteases was 
expected to cause an increased stability of the cysteine proteases used in this study, 
however, this was not observed using the TSA. E-64 did not generate a shift in the TM 
of papain and TcoCATLcat regardless of the concentration tested or the pH of the buffer 
used in the assay. The inability of an irreversible inhibitor to affect a shift in TM within 
the thermal shift assay has been observed previously (Rojas et al, 2015) and explained 
best within a review by Holdgate and Ward (2005). Within this review, the authors 
discussed the requirements for a TM prediction assay to be valid. Specifically, they 
stated that ligand must not bind to the unfolded state of the protein, the ligand 
concentration must be greater than the equilibrium dissociation constant and that the 
complex transition between the unbound protein and the bound protein must be 
reversible (Holdgate and Ward, 2005). The reversible nature of the complex contributes 
towards the free energy of binding and the thermodynamic equilibrium within the 
system. As such, the use of an irreversible inhibitor prevents the accurate calculation of 
the free energy of binding as the thermodynamic equilibrium cannot be attained 
(Holdgate and Ward, 2005). 
Due to the inability to detect a shift in the TM of the relevant proteins by introducing E-
64 as an inhibitor, the reversible inhibitor chymostatin was selected to serve as a 
positive control. Chymostatin was initially isolated from the filtrates of seven strains of 
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actinomycetes by Umezawa et al (1970) and was found to inhibit chymotrypsin and 
also papain to some extent. The isolated inhibitor appeared as three different forms 
which are chymostatin A, B and C with chymostatin A making up the majority of the 
mixture (Stein and Strimpler, 1987). Chymostatin is a covalent reversible protease 
inhibitor of mainly serine proteases but also binds weakly to cysteine proteases. The 
inhibitory activity of the protease is primarily due to the C-terminal phenylalanine 
aldehyde group which is responsible for the formation of a hemithiolacetal adduct with 
the nucleophilic thiol group of the cysteine protease (Umezawa, 1982; Tomkinson et 
al, 1992). There was also observed hydrogen bonding between the main chain of the 
enzyme and part of the main chain of the protease which was shown to stabilise the 
interaction (Umezawa, 1982; Tomkinson et al, 1992). Chymostatin has been identified 
as a non-toxic inhibitor and has been well tolerated in numerous intact cell systems 
(Place et al, 1987; Tomkinson et al, 1992). The inhibition of TcoCATLcat using 
chymostatin was demonstrated previously by Mendoza-Palomares et al, 2008, which 
provided evidence that chymostatin would be suitable for use in this study. 
In this study, chymostatin was shown to effectively bind both papain and TcoCATLcat 
as evidenced by a shift in TM was observed for both of the cysteine proteases in the 
thermal shift assay. The increase in TM observed for the binding of a ligand to a protein 
has been observed to be proportionate to the concentration and affinity of the ligand 
being tested (Cimmperman et al, 2008) and this was observed for both papain and 
TcoCATLcat. The increasing concentrations of chymostatin resulted in an increase in 
the TM of papain and TcoCATLcat where it was observed that 50 µM chymostatin 
resulted in the greatest shift in TM of the cysteine proteases. Perhaps, most notably, the 
TM of TcoCATLcat shifted significantly when in the presence of chymostatin from 47.12 
± 0.16 to 62.43 ± 0.27. As it was established earlier in the study that the lower melting 
temperature is indicative of dimer dissociation while the higher melting temperature is 
indicative of monomer unfolding, it was concluded that chymostatin binds to and 
stabilises the monomeric form of TcoCATLcat. Thereafter, the ChemBridge library of 
compounds were tested at a concentration of 10 µM in order to identify compounds 
capable of stabilising both cysteine proteases. However, none of the 50 compounds 
were able to stabilise papain or TcoCATLcat under the physiological conditions. This 
indicated that the compounds were incapable of binding to papain and TcoCATLcat or, 
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alternatively, the compound library may contain irreversible inhibitors which were not 
detected within the thermal shift assay. 
4.4.3. Increased protease stabilisation by pH manipulation and ligand binding 
The combination of chymostatin (at 50 µM) and the Reinhard buffer library was 
evaluated to determine the impact of combining pH manipulation and ligand binding 
on the stability of papain and TcoCATLcat. Here, it was observed that the combination 
of both factors resulted in the further stabilisation of both cysteine proteases and a 
maximum TM was obtained for the cysteine proteases which surpassed the TM of papain 
and TcoCATLcat when influenced by a single factor (pH or ligand). The affinity of 
chymostatin to bind to either cysteine proteases was, however, reduced under acidic 
conditions where the pH < 4.5.  The melting points obtained under these low pH 
conditions revealed that the cysteine proteases appeared more stable in the absence of 
chymostatin. The ability for the thermal shift assay to detect changes in stability due to 
the combination of pH change and ligand binding may hold greater value when optimal 
activity of the protease is of importance. In this study, it was observed that the greatest 
increase in stability of TcoCATLcat was attributed to the combination of pH and ligand 
when sodium citrate pH 6.0 and 50 µM chymostatin was used. Under these conditions, 
the TM increased by 3.17°C from 58.18 ± 0.06°C to 61.35 ± 0.09°C , illustrating that 
the protease can be further stabilised by the addition of a ligand at a pH which favors 
optimal activity of the protease. 
4.5. The robustness and limitations of the thermal shift assay 
The thermal shift assay has become one of the primary methods utilised in the discovery 
of novel ligands which are capable of stabilising the target protein, the positive 
identification of stabilising ligands can thereafter be confirmed using other methods 
(Senisterra et al, 2010; Huynh and Partch, 2016). The assay has been regarded as a 
small-scale and high-throughput technique, however, this depends on the RT-PCR 
machine used, the availability of purified protein, pre-made buffer or additive screens 
availability as these contribute towards time delays (Senisterra et al, 2010; Huynh and 
Partch, 2016). An RT-PCR machine equipped with a 96-well plate reader is better 
suited for high-throughput as compared to a RT-PCR machine equipped with a rotor 




According to Cimmperman et al (2008) the thermal shift assay has the ability to 
distinguish between weak and strong binding interactions when screening a library of 
compounds and this was described as one of the main advantages the assay holds over 
previously described methods used to determine the thermal stability of a protein. The 
assay was shown to determine the binding of weak ligands which was not detected by 
isothermal titration calorimetry. Another key advantage noted by Cimmperman et al 
(2008) was the low concentration of pure protein required for the assay. The assay was 
shown to provide valid results when the protein concentration used was 2 µM for a 
protein with molecular mass of 35 kDa (Niesen et al, 2007; Cimmperman et al, 2008).   
The requirements of the thermal shift assay may preclude the use of certain proteins. 
For instance, a protein with high surface hydrophobicity is not suitable for use within 
the thermal shift assay. This is due to the binding of SYPRO orange to these 
hydrophobic regions before the protein has unfolded, resulting in an incorrect melting 
temperature and an initial high fluorescence. This initial high fluorescence was also 
described as an event linked to protein aggregation. Therefore, the thermal shift assay 
would not be able to generate valid melt curves when dealing with a protein which has 
hydrophobic clusters present on the surface of the protein and when a protein has 
undergone aggregation. This phenomenon of protein aggregation, although not 
observed in this study, may be overcome by using the thermal shift assay to determine 
optimal conditions which prevent the protein from aggregating. This would be evident 
from the generation of a valid melt curve under optimal conditions.  
A limiting factor of the thermal shift assay is that the melting point of a protein cannot 
exceed 95-100°C as this would cause the water present in samples to evaporate in an 
open plate-based method (Cimmperman et al, 2008). This temperature range is also a 
limitation due to the heating capability of the RT-PCR machine used. Another limiting 
factor explained by Kroeger et al (2017) was the result of quenched fluorescence of 
SYPRO orange due to the presence of EDTA. The quenched fluorescence was only 
observed when EDTA was used as a buffer component at pH > 9. 
Ethylenediaminetetraacetic acid is a chelating agent of metal ions and a common agent 
used in buffers which was used as a buffer component. It was observed that in the 
absence of a protein sample there are interactions between EDTA and SYPRO orange 
at pH > 9 which resulted in the formation of supramolecular EDTA aggregates (Kroeger 
et al, 2017). These aggregates formed in a temperature-dependent manner and provided 
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a fluorescence signal similar to that obtained when a protein unfolds. The contributions 
of fluorescence resulted in incorrect melt plots for a protein. Therefore, EDTA cannot 
be used as a buffer component if a pH > 9 is required and SYPRO orange is the dye of 
choice. In this study, a pH range between 4 and 8 was used and therefore EDTA did not 
affect the fluorescence obtained. 
The thermal shift assay is one of many techniques capable of measuring the stability of 
a protein, however, it is quickly becoming recognised as one of the simplest and least 
expensive methods (Niesen et al, 2007; Senisterra et al, 2010; Huynh and Partch, 2016). 
The ability of the assay to rapidly test many samples using a minimal protein 
concentration without the use of expensive equipment and the simple processing of data 
has led to the thermal shift assay becoming one of the leading assays in drug discovery 
studies focused on the detection of novel ligands (Andreotti et al, 2015). The assay has 
been described as robust and reproducible which is further supported by the low 
standard deviations calculated for each experiment run within this study. 
4.6. Conclusion 
The thermal shift assay was effective in determining the melting temperature for papain 
under physiological conditions of 79.22 ± 0.06°C. The dissociation of the dimer for the 
catalytic domain of congopain under physiological conditions was detected at a melting 
temperature of 47.12 ± 0.16°C while the unfolding of the monomer was determined at 
temperatures exceeding 60°C. The thermal shift assay was able to identify pH and 
ligand binding as factors which contribute to protein stability and optimum conditions 
were determined for papain and TcoCATL. The most stable form of papain was 
observed at pH 5.0 with 50 µM chymostatin which was more stable than papain under 
physiological conditions as evidenced by an increase in TM of 5.23°C. Similarly, the 
most stable form of TcoCATLcat was also determined to be pH 5.0 with 50 µM 
chymostatin while it was additionally shown that chymostatin binds to the monomeric 
and not the dimer form of the protein. Taken together, these findings hold value for 
further biochemical investigation of the two cysteine proteases and may provide useful 
guidelines to facilitate efforts to crystallise TcoCATLcat. This study also established the 
thermal shift assay to be a quick and efficient tool in detecting changes in the melting 




4.7. Future Studies 
The thermal stability of papain and the catalytic domain of congopain were both 
increased due to pH optimisation and the introduction of a known cysteine protease 
inhibitor. The 50 compounds obtained from ChemBridge library of compounds were 
unsuccessful in stabilising the cysteine proteases and thus we were unsuccessful in 
identifying new compounds which bound to papain or the catalytic domain of 
congopain. To rule out the possibility of the presence of irreversible inhibitors, the 
activity of the proteins in the presence of each compound should be evaluated by 
zymogram analysis. The thermal stability of both proteases should then be further 
evaluated by testing different sets of buffer libraries and testing larger compound 
libraries. A larger library of known cysteine protease inhibitors should also be screened 
to determine if any can further stabilise the cysteine proteases to a greater degree than 
was observed for chymostatin. Further evaluation of the thermal stability of the catalytic 
domain of congopain may provide favourable conditions. The optimised conditions 
may then be used in attempts to crystallise the highly relevant cysteine protease which 
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Table A.1: The chemical structures of the 50 compounds obtained from the 
ChemBridge library of compounds  

















































































































































































oxy] benzaldehyde oxime 
 
6943696 
1-
[cyclohexyl(methyl)amino]-
3-(4-methoxyphenoxy)-2-
propanol hydrochloride 
 
6950620 
4-[4-(4-chlorophenyl)-1,3-
thiazol-2-yl]-N, N-dimethyl-
1-piperazinecarboxamide 
 
7275637 
1-(4-chlorophenyl)-4-
(tetrahydro-2-
furanylcarbonyl) piperazine 
 
7293667 
3-cyclopentyl-N-(4-
pyridinylmethyl) 
propanamide 
 
95 
 
7294926 
ethyl 5-
[(dimethylamino)carbonyl]-
2-[(methoxycarbonyl)amino]-
4-methyl-3-
thiophenecarboxylate 
 
7299305 
1-(2-ethylhexanoyl)-3,5-
dimethyl-1H-pyrazole 
 
7364709 
3-(4-chlorophenyl)-N-(2-
methoxy-1-methylethyl) 
acrylamide 
 
7951028 
2-{4-[3-(methylamino)-4-
nitrophenyl]-1-piperazinyl} 
ethanol 
 
7952968 
2-(cyclopentylamino)-N-(4-
methoxy-2,5-
dimethylphenyl)-2-
thioxoacetamide 
 
7953011 
N-({[2-chloro-5-
(trifluoromethyl) phenyl] 
amino} carbonyl)-2,2,2-
trifluoroacetamide 
 
7953379 
N-(4-chloro-2,5-
dimethoxyphenyl)-7-(2,4-
dichlorophenyl)-5-methyl-
4,7-dihydro [1,2,4] 
triazolo[1,5-a] pyrimidine-6-
carboxamide 
 
96 
 
7953623 
6-(1,3-benzodioxol-5-yl)-
1,3,5-triazinane-2,4-dithione 
 
7955822 
4-bromo-1-(2,6-
dichlorobenzyl)-1H-pyrazole 
 
7959564 
4,5-dimethyl-2-(4-
nitrophenyl)-1H-imidazol-1-
ol 3-oxide 
 
 
 
 
